

    <!DOCTYPE html>
<html class="">

        
<head>
    <title>Recent advances in the management and understanding... | F1000Research</title>
    <meta charset="utf-8">
    <!--<meta http-equiv="Content-Type" content="text/html; charset=utf-8"/>-->
    <!--<meta lang="$locale">-->
    <meta http-equiv="X-UA-Compatible" content="IE=edge">
    <meta name="google-site-verification" content="9-QVycOO2_ob3Z9QzRmXv2CF08A9oyYXqWyTiVdKPlU" />
    <!-- This is commented out to fix display problems on mobile devices.
    We may use it again once we implement a responsive design that supports native device resolutions.
    <meta name="viewport" content="width=device-width"> -->

    <meta name="viewport" content="width=device-width, initial-scale=1, maximum-scale=1">



    <link rel="alternate" title="Recent articles published in F1000Research" href="/rss" type="application/rss+xml">
            <link rel="alternate" type="application/pdf" title="PDF" href="https://f1000research.com/articles/6-2063/pdf"/>
        <link rel="canonical" href="https://f1000research.com/articles/6-2063" />
    
            <meta name="description" content="Read the original article in full on F1000Research: Recent advances in the management and understanding of diabetic retinopathy" />
    
            <meta name="og:title" content="F1000Research Article: Recent advances in the management and understanding of diabetic retinopathy.">
            <meta name="og:description" content="Read the latest article version by Matthew Powers, Margaret Greven, Robert Kleinman, Quan Dong Nguyen, Diana Do, at F1000Research.">
            <meta name="og:image" content="/img/sharing/og_research.png">
            <meta name="version-id" content="13709">
            <meta name="article-id" content="12662">
            <meta name="dc.title" content="Recent advances in the management and understanding of diabetic retinopathy">
            <meta name="dc.description" content="Despite recent advances in the diagnosis and treatment of diabetic retinopathy, this complication remains a steadfast challenge to patients and physicians. This review summarizes recent progress in the diagnosis and management of diabetic retinopathy, including automated screening, optical coherence tomography, control of systemic risk factors, surgical techniques, laser treatment, and pharmaceutical treatment, including vascular endothelial growth factor inhibitors. Recent advances in pharmaceutical treatments, in particular, hold strong promise of halting and sometimes reversing the disease process. Clinicians nevertheless must remain vigilant in their efforts to diagnose and treat this disease early in its course.">
            <meta name="dc.subject" content="diabetic retinopathy, diagnosis, treatment, screening, optical coherence tomography, laser treatment, vascular endothelial growth factor inhibitors">
            <meta name="dc.creator" content="Powers, Matthew">
            <meta name="dc.creator" content="Greven, Margaret">
            <meta name="dc.creator" content="Kleinman, Robert">
            <meta name="dc.creator" content="Nguyen, Quan Dong">
            <meta name="dc.creator" content="Do, Diana">
            <meta name="dc.date" content="2017/11/29">
            <meta name="dc.identifier" content="doi:10.12688/f1000research.12662.1">
            <meta name="dc.source" content="F1000Research 2017 6:2063">
            <meta name="dc.format" content="text/html">
            <meta name="dc.language" content="en">
            <meta name="dc.publisher" content="F1000 Research Limited">
            <meta name="dc.rights" content="https://creativecommons.org/licenses/by/3.0/igo/">
            <meta name="dc.type" content="text">
            <meta name="prism.keyword" content="diabetic retinopathy">
            <meta name="prism.keyword" content="diagnosis">
            <meta name="prism.keyword" content="treatment">
            <meta name="prism.keyword" content="screening">
            <meta name="prism.keyword" content="optical coherence tomography">
            <meta name="prism.keyword" content="laser treatment">
            <meta name="prism.keyword" content="vascular endothelial growth factor inhibitors">
            <meta name="prism.publication.Name" content="F1000Research">
            <meta name="prism.publicationDate" content="2017/11/29">
            <meta name="prism.volume" content="6">
            <meta name="prism.number" content="2063">
            <meta name="prism.versionIdentifier" content="1">
            <meta name="prism.doi" content="10.12688/f1000research.12662.1">
            <meta name="prism.url" content="https://f1000research.com/articles/6-2063">
            <meta name="citation_title" content="Recent advances in the management and understanding of diabetic retinopathy">
            <meta name="citation_abstract" content="Despite recent advances in the diagnosis and treatment of diabetic retinopathy, this complication remains a steadfast challenge to patients and physicians. This review summarizes recent progress in the diagnosis and management of diabetic retinopathy, including automated screening, optical coherence tomography, control of systemic risk factors, surgical techniques, laser treatment, and pharmaceutical treatment, including vascular endothelial growth factor inhibitors. Recent advances in pharmaceutical treatments, in particular, hold strong promise of halting and sometimes reversing the disease process. Clinicians nevertheless must remain vigilant in their efforts to diagnose and treat this disease early in its course.">
            <meta name="citation_description" content="Despite recent advances in the diagnosis and treatment of diabetic retinopathy, this complication remains a steadfast challenge to patients and physicians. This review summarizes recent progress in the diagnosis and management of diabetic retinopathy, including automated screening, optical coherence tomography, control of systemic risk factors, surgical techniques, laser treatment, and pharmaceutical treatment, including vascular endothelial growth factor inhibitors. Recent advances in pharmaceutical treatments, in particular, hold strong promise of halting and sometimes reversing the disease process. Clinicians nevertheless must remain vigilant in their efforts to diagnose and treat this disease early in its course.">
            <meta name="citation_keywords" content="diabetic retinopathy, diagnosis, treatment, screening, optical coherence tomography, laser treatment, vascular endothelial growth factor inhibitors">
            <meta name="citation_journal_title" content="F1000Research">
            <meta name="citation_author" content="Matthew Powers">
            <meta name="citation_author_institution" content="Byers Eye Institute, Stanford University School of Medicine, 2452 Watson Court, Palo Alto, CA, 94303, USA">
            <meta name="citation_author" content="Margaret Greven">
            <meta name="citation_author_institution" content="Byers Eye Institute, Stanford University School of Medicine, 2452 Watson Court, Palo Alto, CA, 94303, USA">
            <meta name="citation_author" content="Robert Kleinman">
            <meta name="citation_author_institution" content="Byers Eye Institute, Stanford University School of Medicine, 2452 Watson Court, Palo Alto, CA, 94303, USA">
            <meta name="citation_author" content="Quan Dong Nguyen">
            <meta name="citation_author_institution" content="Byers Eye Institute, Stanford University School of Medicine, 2452 Watson Court, Palo Alto, CA, 94303, USA">
            <meta name="citation_author" content="Diana Do">
            <meta name="citation_author_institution" content="Byers Eye Institute, Stanford University School of Medicine, 2452 Watson Court, Palo Alto, CA, 94303, USA">
            <meta name="citation_publication_date" content="2017/11/29">
            <meta name="citation_volume" content="6">
            <meta name="citation_publication_number" content="2063">
            <meta name="citation_version_number" content="1">
            <meta name="citation_doi" content="10.12688/f1000research.12662.1">
            <meta name="citation_firstpage" content="2063">
            <meta name="citation_pdf_url" content="https://f1000research.com/articles/6-2063/v1/pdf">
    

    
    <link href="/img/favicon-research.ico" rel="shortcut icon" type="image/ico">
    <link href="/img/favicon-research.ico" rel="icon" type="image/ico">

        <link rel="stylesheet" href="/1597255280893/css/mdl/material-design-lite.css" type="text/css" media="all" />
    <link href="https://fonts.googleapis.com/icon?family=Material+Icons" rel="stylesheet">
    <link href="https://fonts.googleapis.com/css?family=Roboto:100,100i,300,300i,400,400i,500,500i,700,700i,900,900i" rel="stylesheet">
    <link rel="stylesheet" href="https://cdnjs.cloudflare.com/ajax/libs/MaterialDesign-Webfont/2.2.43/css/materialdesignicons.min.css" />

        
            
    <link rel="stylesheet" href="/1597255280893/css/F1000Research.css" type="text/css" media="all" />
    <link rel="stylesheet" href="/css/F1000ResearchFontIcons/F1000ResearchFontIcons.css" type="text/css" media="all" />
    <link rel="stylesheet" href="/css/F1000ResearchFontIcons/animation.css" type="text/css" media="all" />

        <!--[if IE 7]><link rel="stylesheet" href="/css/F1000ResearchFontIcons/F1000ResearchFontIcons-ie7.css" media="all" /><![endif]-->

                    <script>dataLayer = [];</script>
        <!-- Google Tag Manager -->
        <script>(function(w,d,s,l,i){w[l]=w[l]||[];w[l].push({'gtm.start':
        new Date().getTime(),event:'gtm.js'});var f=d.getElementsByTagName(s)[0],
        j=d.createElement(s),dl=l!='dataLayer'?'&l='+l:'';j.async=true;j.src=
        'https://www.googletagmanager.com/gtm.js?id='+i+dl;f.parentNode.insertBefore(j,f);
        })(window,document,'script','dataLayer','GTM-54Z2SBK');</script>
        <!-- End Google Tag Manager -->
    
    <script src="https://ajax.googleapis.com/ajax/libs/jquery/1.8.1/jquery.min.js"></script>
    <script>window.jQuery || document.write('<script src="/js/vendor/jquery-1.8.1.min.js"><\/script>')</script>
    <script src="/1597255280893/js/vendor/modernizr-2.6.1-respond-1.1.0.min.js"></script>
    <script src="/1597255280893/js/shared_scripts/sticky.js"></script>
    <script src="/1597255280893/js/shared_scripts/helpers.js"></script>
    <script src="/1597255280893/js/shared_scripts/menu.js"></script>
    <script src="/1597255280893/js/shared_scripts/navbar.js"></script>
    <script src="/1597255280893/js/shared_scripts/platforms.js"></script>
    <script src="/1597255280893/js/shared_scripts/object-polyfills.js"></script>
            <script src="/1597255280893/js/vendor/lodash.min.js"></script>
        <script>CKEDITOR_BASEPATH='https://f1000research.com/js/ckeditor/'</script>
    <script src="https://f1000researchdata.s3-eu-west-1.amazonaws.com/js/plugins.js"></script>
    <script src="/1597255280893/js/shared_scripts/helpers.js"></script>
    <script src="/1597255280893/js/app/research.js"></script>
    <script>window.reactTheme = 'research';</script>
    <script src="/1597255280893/js/public/bundle.js"></script>

    <script src="/1597255280893/js/app/research.ui.js"></script>
    <script src="/1597255280893/js/app/login.js"></script>
    <script src="/1597255280893/js/app/main.js"></script>
    <script src="/1597255280893/js/app/js-date-format.min.js"></script>
    <script src="/1597255280893/js/app/search.js"></script>
    <script src="/1597255280893/js/app/cookies_warning.js"></script>
    <script src="/1597255280893/js/mdl/mdl.min.js"></script>

    <script src="https://cdnjs.cloudflare.com/ajax/libs/mathjax/2.7.1/MathJax.js?config=TeX-AMS-MML_HTMLorMML"></script>
                <script src="https://f1000researchdata.s3-eu-west-1.amazonaws.com/js/ckeditor.js"></script>
            <script src="/js/ckeditor/adapters/jquery.js"></script>
                <script src="/js/article/article_scrolling_module.js"></script>
            <script src="/js/article/article_stats.js"></script>
            <script src="/js/article/article.js"></script>
            <script src="/js/shared_scripts/referee_timeline_pagination.js"></script>
            <script src="/js/app/text_editor_controller.js"></script>
            <script src="//s7.addthis.com/js/250/addthis_widget.js#pubid=ra-503e5e99593dc42c"></script>
            <script src="/js/article/article_metrics.js"></script>
        
                                                                            <script>
            if (window.location.hash == '#_=_'){
                window.location = window.location.href.split('#')[0]
            }
        </script>

                    
        
    <!-- pixelId: 1641728616063202 :: assetPixelId: 6034867600215 :: funderPixelId:  -->

            <!-- Facebook pixel code (merged with EP GTM code) -->
        <script>
            !function(f,b,e,v,n,t,s){if(f.fbq)return;n=f.fbq=function()

            {n.callMethod? n.callMethod.apply(n,arguments):n.queue.push(arguments)}
            ;if(!f._fbq)f._fbq=n;
            n.push=n;n.loaded=!0;n.version='2.0';n.queue=[];t=b.createElement(e);t.async=!0;
            t.src=v;s=b.getElementsByTagName(e)[0];s.parentNode.insertBefore(t,s)}(window,
            document,'script','https://connect.facebook.net/en_US/fbevents.js');

            fbq('init', '1641728616063202');

            
            fbq('track', "PixelInitialized", {});
        </script>

        <noscript><img height="1" width="1" style="display:none"
            src="https://www.facebook.com/tr?id=1641728616063202&noscript=1&amp;ev=PixelInitialized"
        /></noscript>
        <!-- End Facebook Pixel Code -->
    
                <script>
            (function(h,o,t,j,a,r){
                h.hj=h.hj||function(){(h.hj.q=h.hj.q||[]).push(arguments)};
                h._hjSettings={hjid:917825,hjsv:6};
                a=o.getElementsByTagName('head')[0];
                r=o.createElement('script');r.async=1;
                r.src=t+h._hjSettings.hjid+j+h._hjSettings.hjsv;
                a.appendChild(r);
            })(window,document,'https://static.hotjar.com/c/hotjar-','.js?sv=');
        </script>
    
</head>
<body  class="o-page-container no-js p-article o-layout-reset   ">

    
                            <!-- Google Tag Manager (noscript) -->
        <noscript><iframe src="https://www.googletagmanager.com/ns.html?id=GTM-54Z2SBK"
        height="0" width="0" style="display:none;visibility:hidden"></iframe></noscript>
        <!-- End Google Tag Manager (noscript) -->
    
        
    <div class="o-page">

        <div id="notify-container"></div>
        <div id="pageWarning"></div>
        <div id="pageMessage"></div>
        <div id="pageFooterMessage"></div>

                                <div id="f1r-ga-data" data-name="f1r-ga-data" class="f1r-ga-data"
                data-user-registered="false"
                data-user-module=""
                data-current-path=""
                data-location=""
                data-website="F1000Research"
                data-websiteDisplayName="F1000Research">
            </div>
        
                
        
        <div class="header-wrapper   js-navbar-space ">
                            


    










        
                            
    
            



<nav class="c-navbar js-navbar js-mini-nav js-sticky c-navbar--js-sticky c-navbar--userSite c-navbar__platform-bgcolor  c-navbar--bg-f1000research ">

    <div class="c-navbar__content">

                                <div class="c-navbar__extras">
            <div class="o-wrapper">
                <div class="o-actions o-actions--middle c-navbar__extras-row">
                    <div class="o-actions__primary">
                        
                                            </div>
                                    </div>
            </div>
        </div>

        <div class="o-wrapper t-inverted js-sticky-start">

            <div class="c-navbar__branding-row">
                <div class="c-navbar__row">


                                        
                    <div class="c-navbar__primary u-mr--2">

                                                                                                                                                                                                    <a href="/" class="c-navbar__branding u-ib u-middle"   data-test-id="nav_branding"  >
                                <img class="u-ib u-middle" src="/img/research/F1000Research_white_solid.svg" alt="F1000Research">
                            </a>
                                            </div>

                    <div class="c-navbar__secondary c-navbar__row">


                                                
                                                    <form action="/search" class="-navbar__secondary u-mr--2 c-search-form js-search-form u-hide u-show@navbar">
                                <label for="searchInput" class="c-search-form__label _mdl-layout">
                                    <input name="q" type="search" class="c-search-form__input" id="searchInput" placeholder="Search">
                                    <button type="submit" class="c-search-form__submit mdl-button mdl-js-button mdl-button--icon"><i class="material-icons">search</i></button>
                                </label>
                            </form>
                        
                                                
                                                    <div class="c-navbar__primary u-hide u-show@navbar">
                                <div class="_mdl-layout c-navbar__cta">
                                    <a class="mdl-button mdl-js-button mdl-button--raised mdl-button--no-shadow mdl-button--multi-line mdl-js-ripple-effect mdl-button--inverted c-navbar__submit" href="/for-authors/publish-your-research"   data-test-id="nav_submit_research"  ><i class="material-icons">file_upload</i>Submit your research</a>
                                </div>
                            </div>
                        

                                                
                        <span class="u-hide@navbar _mdl-layout u-nowrap">

                                                            <button type="button" class="mdl-button mdl-js-button mdl-js-ripple-effect mdl-button--icon c-navbar__toggle c-navbar__toggle--menu js-navbar-toggle" data-focus="#navbar_mob_search_input" data-toggle="navbarMenu" data-target="navbarMenu" aria-controls="navbarMenu" aria-expanded="false" aria-label="Toggle navigation"   data-test-id="nav_menu_search_mob"  ><i class="material-icons">search</i></button>
                            
                                                            <button class="mdl-button mdl-js-button mdl-js-ripple-effect mdl-button--icon mdl-button--multi-line c-navbar__toggle c-navbar__toggle--menu js-navbar-toggle" type="button" data-toggle="navbarMenu" data-target="navbarMenu" aria-controls="navbarMenu" aria-expanded="false" aria-label="Toggle navigation"   data-test-id="nav_menu_toggle_mob"  >
                                    <i class="material-icons c-navbar__toggle-open">menu</i>
                                    <i class="material-icons c-navbar__toggle-close">close</i>
                                </button>
                                                    </span>
                    </div>

                </div>
            </div>

                        
                            <div class="c-navbar__menu-row js-navbar-block is-collapsed" id="navbarMenu">

                                                                                                                                                
                                                                    
                                                                    
                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                        
                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                        
                                            

                                                                
                                                                                                                                                                                                                                
                                            
                    <div class="c-navbar__menu-row-content">

                                                                            <div class="u-hide@navbar c-navbar__menu-bar-spacing">
                                <form action="/search" class="c-search-form js-search-form">
                                    <label for="navbar_mob_search_input" class="c-search-form__label _mdl-layout">
                                        <input id="navbar_mob_search_input" name="q" type="search" class="c-search-form__input" placeholder="Search">
                                        <button type="submit" class="c-search-form__submit mdl-button mdl-js-button mdl-button--icon"><i class="material-icons">search</i></button>
                                    </label>
                                </form>
                            </div>
                        
                        <div class="o-actions o-actions--middle">

                            <div class="o-actions__primary">

                                                                
    <ul class="c-menubar c-navbar__menu-bar js-main-menu"   id="main-menu"   role="menubar" aria-label="Main Navigation"  data-menu-group="navbar" >

        
            
                                                                
                                
                                
                                    <li role="none"
                        data-index="0"
                        class="c-menubar__item js-menu-item  c-navbar__menu-bar-item
                                                              ">

                        <a href="/browse/articles" class="c-navbar__menu-bar-link js-menu-link " role="menuitem"
                                                                                    tabindex="0"
                              data-test-id="nav_browse"                              >Browse</a>

                                            </li>
                
            
        
            
                                                                
                
                                
                                    <li role="none"
                        data-index="1"
                        class="c-menubar__item js-menu-item  c-navbar__menu-bar-item
                                                              ">

                        <a href="/gateways" class="c-navbar__menu-bar-link js-menu-link " role="menuitem"
                                                                                    tabindex="-1"
                              data-test-id="nav_gatewaysViewAndBrowse"                              >Gateways & Collections</a>

                                            </li>
                
            
        
            
                                                                
                
                                
                                    <li role="none"
                        data-index="2"
                        class="c-menubar__item js-menu-item  c-navbar__menu-bar-item
                                                               c-menubar__item--selected c-navbar__menu-bar-item--parent ">

                        <a href="#" class="c-navbar__menu-bar-link js-menu-link " role="menuitem"
                                                         aria-haspopup="true" aria-expanded="false"                             tabindex="-1"
                              data-test-id="nav_for-authors"                              >How to Publish</a>

                                                    
    <ul class="c-menu js-menu
                is-collapsed                c-menubar__menu c-navbar__menu"
                  role="menu"
        aria-label="How to Publish">

        
            
                                
                                
                <li class="c-menu__item js-menu-item
                                              "
                        role="none">

                <a  class="c-menu__link js-menu-link
                                                      "
                                          data-test-id="nav_submit-manuscript"                      href="/for-authors/publish-your-research"
                    role="menuitem"
                    tabindex="0">Submit your Research</a>

                </li>

                    
            
                
                                
                <li class="c-menu__item js-menu-item
                                              "
                        role="none">

                <a  class="c-menu__link js-menu-link
                                                      "
                                          data-test-id="nav_my-submissions"                      href="/for-authors/my-submissions"
                    role="menuitem"
                    tabindex="-1">My Submissions</a>

                </li>

                    
            
                
                                
                <li class="c-menu__item js-menu-item
                                              "
                        role="none">

                <a  class="c-menu__link js-menu-link
                                                      "
                                          data-test-id="nav_article-guidelines"                      href="/for-authors/article-guidelines"
                    role="menuitem"
                    tabindex="-1">Article Guidelines</a>

                </li>

                    
            
                
                                
                <li class="c-menu__item js-menu-item
                                              "
                        role="none">

                <a  class="c-menu__link js-menu-link
                                                      "
                                          data-test-id="nav_article-guidelines-new-versions"                      href="/for-authors/article-guidelines-new-versions"
                    role="menuitem"
                    tabindex="-1">Article Guidelines (New Versions)</a>

                </li>

                    
            
                
                                
                <li class="c-menu__item js-menu-item
                                              "
                        role="none">

                <a  class="c-menu__link js-menu-link
                                                      "
                                          data-test-id="nav_data-guidelines"                      href="/for-authors/data-guidelines"
                    role="menuitem"
                    tabindex="-1">Data Guidelines</a>

                </li>

                    
            
                
                                
                <li class="c-menu__item js-menu-item
                                              "
                        role="none">

                <a  class="c-menu__link js-menu-link
                                                      "
                                          data-test-id="nav_asset-guidelines"                      href="/for-authors/posters-and-slides-guidelines"
                    role="menuitem"
                    tabindex="-1">Posters and Slides Guidelines</a>

                </li>

                    
            
                
                                
                <li class="c-menu__item js-menu-item
                                              "
                        role="none">

                <a  class="c-menu__link js-menu-link
                                                      "
                                          data-test-id="nav_document-guidelines"                      href="/for-authors/document-guidelines"
                    role="menuitem"
                    tabindex="-1">Document Guidelines</a>

                </li>

                    
            
                
                                
                <li class="c-menu__item js-menu-item
                                              "
                        role="none">

                <a  class="c-menu__link js-menu-link
                                                      "
                                          data-test-id="nav_article-processing-charges"                      href="/for-authors/article-processing-charges"
                    role="menuitem"
                    tabindex="-1">Article Processing Charges</a>

                </li>

                    
            
                
                                
                <li class="c-menu__item js-menu-item
                                              "
                        role="none">

                <a  class="c-menu__link js-menu-link
                                                      "
                                          data-test-id="nav_finding-referees"                      href="/for-authors/tips-for-finding-referees"
                    role="menuitem"
                    tabindex="-1">Finding Article Reviewers</a>

                </li>

                        </ul>
                                            </li>
                
            
        
            
                                                                
                
                                
                                    <li role="none"
                        data-index="3"
                        class="c-menubar__item js-menu-item  c-navbar__menu-bar-item
                                                               c-menubar__item--selected c-navbar__menu-bar-item--parent ">

                        <a href="#" class="c-navbar__menu-bar-link js-menu-link " role="menuitem"
                                                         aria-haspopup="true" aria-expanded="false"                             tabindex="-1"
                              data-test-id="nav_about-contact"                              >About</a>

                                                    
    <ul class="c-menu js-menu
                is-collapsed                c-menubar__menu c-navbar__menu"
                  role="menu"
        aria-label="About">

        
            
                                
                                
                <li class="c-menu__item js-menu-item
                                              "
                        role="none">

                <a  class="c-menu__link js-menu-link
                                                      "
                                          data-test-id="nav_about-page"                      href="/about"
                    role="menuitem"
                    tabindex="0">How it Works</a>

                </li>

                    
            
                
                                
                <li class="c-menu__item js-menu-item
                                              "
                        role="none">

                <a  class="c-menu__link js-menu-link
                                                      "
                                          data-test-id="nav_referee-guidelines"                      href="/for-referees/guidelines"
                    role="menuitem"
                    tabindex="-1">For Reviewers</a>

                </li>

                    
            
                
                                
                <li class="c-menu__item js-menu-item
                                              "
                        role="none">

                <a  class="c-menu__link js-menu-link
                                                      "
                                          data-test-id="nav_advisoryPanel"                      href="/advisors"
                    role="menuitem"
                    tabindex="-1">Our Advisors</a>

                </li>

                    
            
                
                                
                <li class="c-menu__item js-menu-item
                                              "
                        role="none">

                <a  class="c-menu__link js-menu-link
                                                      "
                                          data-test-id="nav_policy-page"                      href="/about/policies"
                    role="menuitem"
                    tabindex="-1">Policies</a>

                </li>

                    
            
                
                                
                <li class="c-menu__item js-menu-item
                                              "
                        role="none">

                <a  class="c-menu__link js-menu-link
                                                      "
                                          data-test-id="nav_glossary-page"                      href="/glossary"
                    role="menuitem"
                    tabindex="-1">Glossary</a>

                </li>

                    
            
                
                                
                <li class="c-menu__item js-menu-item
                                              "
                        role="none">

                <a  class="c-menu__link js-menu-link
                                                      "
                                          data-test-id="nav_faqs-page"                      href="/faqs"
                    role="menuitem"
                    tabindex="-1">FAQs</a>

                </li>

                    
            
                
                                
                <li class="c-menu__item js-menu-item
                                              u-hide u-show@navbar"
                        role="none">

                <a  class="c-menu__link js-menu-link
                                                      u-hide u-show@navbar"
                                          data-test-id="nav_for-developers"                      href="/developers"
                    role="menuitem"
                    tabindex="-1">For Developers</a>

                </li>

                    
            
                
                                
                <li class="c-menu__item js-menu-item
                                              "
                        role="none">

                <a  class="c-menu__link js-menu-link
                                                      "
                                          data-test-id="nav_newsroom-page"                      href="/newsroom"
                    role="menuitem"
                    tabindex="-1">Newsroom</a>

                </li>

                    
            
                
                                
                <li class="c-menu__item js-menu-item
                                              "
                        role="none">

                <a  class="c-menu__link js-menu-link
                                                      "
                                          data-test-id="nav_contact-page"                      href="/contact"
                    role="menuitem"
                    tabindex="-1">Contact</a>

                </li>

                        </ul>
                                            </li>
                
            
        
            
                                                                
                
                                
                                    <li role="none"
                        data-index="4"
                        class="c-menubar__item js-menu-item  c-navbar__menu-bar-item
                                                              ">

                        <a href="https://blog.f1000.com/blogs/f1000research/" class="c-navbar__menu-bar-link js-menu-link " role="menuitem"
                             target="_blank"                                                         tabindex="-1"
                              data-test-id="nav_blog"                              >Blog</a>

                                            </li>
                
            
        
    </ul>



                            </div>

                            <div class="o-actions__secondary">

                                                                
    <ul class="c-menubar c-navbar__menu-bar js-main-menu"   id="secondary-items"   role="menubar" aria-label="My Account"  data-menu-group="navbar" >

        
            
                                                                
                                
                                
                                    <li role="none"
                        data-index="0"
                        class="c-menubar__item js-menu-item  c-navbar__menu-bar-item
                                                               c-menubar__item--selected c-navbar__menu-bar-item--parent ">

                        <a href="#" class="c-navbar__menu-bar-link js-menu-link " role="menuitem"
                                                         aria-haspopup="true" aria-expanded="false"                             tabindex="0"
                              data-test-id="nav_my-research"                              >My Research</a>

                                                    
    <ul class="c-menu js-menu
                is-collapsed                c-menubar__menu c-navbar__menu"
                  role="menu"
        aria-label="My Research">

        
            
                                
                                
                <li class="c-menu__item js-menu-item
                                              "
                        role="none">

                <a  class="c-menu__link js-menu-link
                                                      "
                                          data-test-id="nav_my-submissions"                      href="/login?originalPath=/my/submissions"
                    role="menuitem"
                    tabindex="0">Submissions</a>

                </li>

                    
            
                
                                
                <li class="c-menu__item js-menu-item
                                              "
                        role="none">

                <a  class="c-menu__link js-menu-link
                                                      "
                                          data-test-id="nav_my-email-alerts"                      href="/login?originalPath=/my/email-alerts"
                    role="menuitem"
                    tabindex="-1">Content and Tracking Alerts</a>

                </li>

                    
            
                
                                
                <li class="c-menu__item js-menu-item
                                              "
                        role="none">

                <a  class="c-menu__link js-menu-link
                                                      "
                                          data-test-id="nav_my-user-details"                      href="/login?originalPath=/my/user-details"
                    role="menuitem"
                    tabindex="-1">My Details</a>

                </li>

                        </ul>
                                            </li>
                
            
        
            
                                                                
                
                                
                                    <li role="none"
                        data-index="1"
                        class="c-menubar__item js-menu-item  c-navbar__menu-bar-item
                                                              ">

                        <a href="/login?originalPath=/articles/6-2063.html" class="c-navbar__menu-bar-link js-menu-link " role="menuitem"
                                                                                    tabindex="-1"
                              data-test-id="nav_sign-in"                              >Sign In</a>

                                            </li>
                
            
        
    </ul>



                            </div>

                                                                                        <div class="_mdl-layout c-navbar__cta u-hide@navbar c-navbar__menu-bar-spacing">
                                    <a class="mdl-button mdl-js-button mdl-button--raised mdl-button--multi-line mdl-button--no-shadow mdl-js-ripple-effect mdl-button--inverted c-navbar__submit" href="/for-authors/publish-your-research"   data-test-id="nav_submit_research_mob"  ><i class="material-icons">file_upload</i>Submit your research</a>
                                </div>
                                                    </div>

                    </div>

                </div>
            
        </div>

    </div>

</nav>
                    </div>

        <div class="content-wrapper o-page__main row ">
            <div id="highlight-area" class="content ">
                





<div id=article-metadata class=hidden> <input type=hidden name=versionId value=13709 /> <input type=hidden id=articleId name=articleId value=12662 /> <input type=hidden id=xmlUrl value="/articles/6-2063/v1/xml"/> <input type=hidden id=xmlFileName value="-6-2063-v1.xml"> <input type=hidden id=article_uuid value=5da9cb2b-47ad-4171-83f8-33d1e3155e33 /> <input type=hidden id=referer value=""/> <input type=hidden id=meta-article-title value="Recent advances in the management and understanding of diabetic retinopathy"/> <input type=hidden id=workspace-export-url value="https://sciwheel.com/work/api/import/external?doi=10.12688/f1000research.12662.1"/> <input type=hidden id=versionDoi value="10.12688/f1000research.12662.1"/> <input type=hidden id=usePmcStats value=true /> </div> <main class="o-wrapper p-article__wrapper js-wrapper"> <script type="application/ld+json">
{
  "@context": "https://schema.org",
  "@type": "ScholarlyArticle",
  "mainEntityOfPage": {
    "@type": "WebPage",
    "@id": "https://f1000research.com/articles/6-2063"
  },
  "headline": "Recent advances in the management and understanding of diabetic retinopathy",
  "datePublished": "2017-11-29T11:34:50",
  "dateModified": "2017-11-29T11:34:50",
  "author": [
    {
      "@type": "Person",
      "name": "Matthew Powers"
    },    {
      "@type": "Person",
      "name": "Margaret Greven"
    },    {
      "@type": "Person",
      "name": "Robert Kleinman"
    },    {
      "@type": "Person",
      "name": "Quan Dong Nguyen"
    },    {
      "@type": "Person",
      "name": "Diana Do"
    }  ],
  "publisher": {
    "@type": "Organization",
    "name": "F1000Research",
    "logo": {
      "@type": "ImageObject",
      "url": "https://f1000research.com/img/AMP/F1000Research_image.png",
      "height": 480,
      "width": 60
    }
  },
  "image": {
    "@type": "ImageObject",
    "url": "https://f1000research.com/img/AMP/F1000Research_image.png",
    "height": 1200,
    "width": 150
  },
  "description": "Despite recent advances in the diagnosis and treatment of diabetic retinopathy, this complication remains a steadfast challenge to patients and physicians. This review summarizes recent progress in the diagnosis and management of diabetic retinopathy, including automated screening, optical coherence tomography, control of systemic risk factors, surgical techniques, laser treatment, and pharmaceutical treatment, including vascular endothelial growth factor inhibitors. Recent advances in pharmaceutical treatments, in particular, hold strong promise of halting and sometimes reversing the disease process. Clinicians nevertheless must remain vigilant in their efforts to diagnose and treat this disease early in its course."
}
</script> <div class="o-layout o-layout--right-gutter"> <div id=article_secondary-column class="p-article__main o-layout__item u-font-size--legal u-2/3@article not-expanded "> <div class=float-left> <script type="application/ld+json">
  {
    "@context": "http://schema.org",
    "@type": "BreadcrumbList",
    "itemListElement": [
              {
          "@type": "ListItem",
          "position": "1",
          "item": {
            "@id": "https://f1000research.com/",
            "name": "Home"
          }
        },              {
          "@type": "ListItem",
          "position": "2",
          "item": {
            "@id": "https://f1000research.com/browse/articles",
            "name": "Browse"
          }
        },              {
          "@type": "ListItem",
          "position": "3",
          "item": {
            "@id": "https://f1000research.com/articles/6-2063",
            "name": "Recent advances in the management and understanding of diabetic retinopathy"
          }
        }          ]
  }
  </script> <div class="breadcrumbs js-breadcrumbs"> <a href="/" class=f1r-standard-link>Home</a> <span class=item_separator></span> <a href="/browse/articles" class=f1r-standard-link>Browse</a> <span class=item_separator></span> Recent advances in the management and understanding of diabetic retinopathy </div> </div> <div class="article-badges-container u-mb--2"> <div class=crossmark-new> <script src="https://crossmark-cdn.crossref.org/widget/v2.0/widget.js"></script> <a data-target=crossmark><img height=30 width=150 src="https://crossmark-cdn.crossref.org/widget/v2.0/logos/CROSSMARK_Color_horizontal.svg"/></a> </div> <div id=crossmark-dialog style="display: none;" title=""> <iframe id=crossmark-dialog-frame frameborder=0></iframe> </div> <div class=clearfix></div> </div> <div class=article-interaction-container> <div id=main-article-count-box class=article-count-box> <div class="article-metrics-wrapper metrics-icon-wrapper" data-version-id=13709 data-id=12662 data-downloads="" data-views="" data-scholar="10.12688/f1000research.12662.1" data-recommended="" data-doi="10.12688/f1000research.12662.1" data-f1r-ga-helper="Article Page Metrics (Desktop)"> <span class="metrics-on-browse article-metrics-icon f1r-icon icon-89_metrics"></span> <div class="count-title article-metrics-text">ALL Metrics</div> <div class=js-article-metrics-container></div> </div> <div> <div class=count-delimiter></div> <div title="Total views from F1000Research and PubMed Central"> <div class="count-container view-count js-views-count">-</div> <div class=count-title><span class="count-title-icon count-title-views-icon"></span>Views</div> </div> <div class=download-counts hidden> <div class=count-delimiter></div> <div title="Total downloads from F1000Research and PubMed Central"> <div class="count-container js-downloads-count"></div> <div class=count-title><span class="count-title-icon f1r-icon icon-76_download_file"></span>Downloads</div> </div> </div> </div> </div> <div id=main-article-interaction-box class="article-interaction-box has-control-tab"> <div class="article-interaction-info article-page"> <div class=article-interaction-button> <span class="f1r-icon icon-102_download_pdf"></span> <a href="https://f1000research.com/articles/6-2063/v1/pdf?article_uuid=5da9cb2b-47ad-4171-83f8-33d1e3155e33" title="Download PDF" class="button-link download pdf-download-helper" target=_blank>Get PDF</a> </div> </div> <div class="article-interaction-info article-page"> <div class=article-interaction-button> <span class="f1r-icon icon-103_download_xml"></span> <a id=download-xml href="#" class="button-link download" title="Download XML">Get XML</a> </div> </div> <div class="article-interaction-info article-page"> <div class="cite-article-popup-wrapper article-page-interaction-box"> <div class="article-interaction-button cite-article-button" title="Cite this article" data-windowref=cite-article-popup-12662-1> <span class="f1r-icon icon-82_quote"></span> <a href="#" class="button-link cite-article-popup-link" title="Cite Article">Cite</a> </div> <div id=cite-article-popup-12662-1 class="popup-window-wrapper is-hidden"> <div class=cite-popup-background></div> <div class="popup-window top-popup cite-this-article-box research-layout"> <div class="popup-window-title small cite-title">How to cite this article</div> <span id=cite-article-text-12662-1 data-test-id=copy-citation_text> <span class="article-title-and-info in-popup">Powers M, Greven M, Kleinman R <em>et al.</em> Recent advances in the management and understanding of diabetic retinopathy [version 1; peer review: 2 approved]</span>. <i>F1000Research</i> 2017, <b>6</b>(F1000 Faculty Rev):2063 (<a class=new-orange href="https://doi.org/10.12688/f1000research.12662.1" target=_blank>https://doi.org/10.12688/f1000research.12662.1</a>) </span> <div class="popup-window-title small margin-top-20 margin-bottom-20 note"> <strong>NOTE:</strong> it is important to ensure the information in square brackets after the title is included in all citations of this article. </div> <div class=float-right> <button class="secondary no-fill orange-text-and-border margin-right-20 close-cite-popup uppercase">Close</button> <button id=copy-citation-details class="secondary orange copy-cite-article-version uppercase js-clipboard" title="Copy the current citation details to the clipboard." data-clipboard-target="#cite-article-text-12662-1" data-test-id=copy-citation_button>Copy Citation Details</button> </div> </div> </div> </div> </div> <div class="article-interaction-info article-page"> <div class=article-interaction-button> <span class="f1r-icon icon-76_download_file"></span> <a id=export-citation href="#" class="button-link download" title="Export Citation">Export</a> </div> <div class="modal-window-wrapper is-hidden"> <div id=export-citation-popup class="modal-window padding-20"> <div class=modal-window-close-button></div> <div class=modal-window-title>Export Citation</div> <div class=modal-window-row> <div> <input type=radio name=export-citation-option value=WORKSPACE /> <span class=radio-label>Sciwheel</span> </div> <div> <input type=radio name=export-citation-option value=ENDNOTE /> <span class=radio-label>EndNote</span> </div> <div> <input type=radio name=export-citation-option value=REF_MANAGER /> <span class=radio-label>Ref. Manager</span> </div> <div> <input type=radio name=export-citation-option value=BIBTEX /> <span class=radio-label>Bibtex</span> </div> <div> <input type=radio name=export-citation-option value=PROCITE /> <span class=radio-label>ProCite</span> </div> <div> <input type=radio name=export-citation-option value=SENTE /> <span class=radio-label>Sente</span> </div> </div> <div class=modal-window-footer> <button class=general-white-orange-button id=export-citation-submit>EXPORT</button> </div> <div class=default-error style="display: none;">Select a format first</div> </div> </div> </div> <div class="article-interaction-info article-page"> <div class=article-interaction-button> <span class="f1r-icon icon-90_track"></span> <a class="button-link track-article" data-article-id=12662 id=track-article-signin-12662 title="Receive updates on new activity such as publication of new versions, peer reviews or author responses." href="/login?originalPath=/trackArticle/12662?target=/articles/6-2063">Track</a> </div> </div> <div class="article-interaction-info article-page"> <div class="article-interaction-button email-article"> <span class="f1r-icon icon-6_email"></span> <a href="#" class=button-link title="Email this article">Email</a> </div> <div class="email-article-version-container small-tooltip _chrome-fix"> <div class=close-icon><span class="f1r-icon icon-3_close_big"></span></div> <script src='https://www.recaptcha.net/recaptcha/api.js'></script> <form class="recommend-version-form research-layout"> <p>All fields are required.</p> <input name=versionId type=hidden value=13709 /> <input name=articleId type=hidden value=12662 /> <input name=senderName class="form-input-field reg-form" value="" type=text placeholder="Your name"/> <input name=senderEmail class="form-input-field reg-form margin-top" value="" type=text placeholder="Your email address"/> <textarea name=recipientEmails class="form-textarea-field ninetynine-percent-wide margin-top no-resize" placeholder="Recipient email address(es) (comma delimited)"></textarea> <input class="form-input-field reg-form margin-top" name=subject type=text value="Interesting article on F1000Research" placeholder=Subject /> <textarea name=message class="form-textarea-field reg-form margin-top no-resize">I thought this article from F1000Research (https://f1000research.com) would be of interest to you.</textarea> <div class="g-recaptcha margin-top" data-sitekey=6LcHqxoUAAAAANP3_0TzpGG6qFvl4DhbUcuRzw7W></div> <input value="" name=captcha type=hidden /> <p>A full article citation will be automatically included.</p> <p><img class="ticker-email-article-details hidden" src="/img/ticker.gif" alt=loading /></p> <button class="secondary orange margin-bottom" data-test-id=version_share_email_send>SEND EMAIL</button> <div class="orange-message margin-bottom is-hidden" data-test-id=version_share_email_message></div> </form> </div> </div> <div class="article-interaction-info article-page"> <div class=article-interaction-button> <span class="f1r-icon icon-34_share"></span> <a href="#" class="button-link last addthis_button share-article" title="Share this article">Share</a> </div> </div> </div> <div id=article-interaction-control-tab class=article-interaction-control-tab> <div id=hide-article-interaction class=article-interaction-control title="Hide Toolbox">&#9644;</div> <div id=show-article-interaction class="article-interaction-control open" title="Show Toolbox">&#10010;</div> </div> </div> <div class="article-header-information article-page"> <div class="f1r-article-mobile article-heading-bar"></div> <div class="article-type article-display">Review </div> <div class="article-title-and-info article-view highlighted-article" id=anchor-title> <h1>Recent advances in the management and understanding of diabetic retinopathy</h1><span class=other-info> [version 1; peer review: 2 approved]</span> </div> <div class=article-subtitle></div> <div class=f1r-article-desk> <div class="authors _mdl-layout"><span class="">Matthew Powers<a href="https://orcid.org/0000-0002-2257-0309" target=_blank id=author-orcid-0><span class=orcid-logo-for-author-list></span></a><div class="mdl-tooltip mdl-tooltip--wider" for=author-orcid-0><span class=orcid-logo-for-author-list></span> https://orcid.org/0000-0002-2257-0309</div>,&nbsp;</span><span class="">Margaret Greven,&nbsp;</span><span class="">Robert Kleinman,&nbsp;</span><span class="">Quan Dong Nguyen,&nbsp;</span><span class=""><a href="mailto:dianado@stanford.edu" title="Send email" class="cauthor research-layout"><span class='f1r-icon icon-6_email orange'></span><span>Diana Do</span></a></span></div> </div> <div class=f1r-article-mobile> <div class="authors _mdl-layout"><span class="">Matthew Powers<a href="http://orcid.org/0000-0002-2257-0309" target=_blank id=mauthor-orcid-0><span class=orcid-logo-for-author-list></span></a><div class="mdl-tooltip mdl-tooltip--wider" for=mauthor-orcid-0><span class=orcid-logo-for-author-list></span> https://orcid.org/0000-0002-2257-0309</div>,&nbsp;</span><span class="">Margaret Greven,&nbsp;</span><a href="#" class=article-page-expand-authors>[...]&nbsp;</a><span class=article-page-hidden-authors>Robert Kleinman,&nbsp;</span><span class="">Quan Dong Nguyen,&nbsp;</span><span class=""><a href="mailto:dianado@stanford.edu" title="Send email" class="cauthor research-layout"><span class='f1r-icon icon-6_email orange'></span><span>Diana Do</span></a></span><span class="author-display-control article-page-expand-authors f1r-icon icon-20_plus_big"></span><span class="author-display-control article-page-hidden-authors f1r-icon icon-12_minus_big"></span></div> </div> <div class=f1r-article-mobile> <div class=article-pubinfo-mobile> PUBLISHED 29 Nov 2017 </div> </div> <span class=Z3988 title="ctx_ver=Z39.88-2004&amp;rft_val_fmt=info:ofi/fmt:kev:mtx:journal&amp;rft_id=info:doi/10.12688%2Ff1000research.12662.1"></span> <div class=f1r-article-desk> <div class="contracted-details first"> <a href="#" class="contracted-details-label author-affiliations"><span class=contracted></span>Author details</a> <a href="#" class=section-title>Author details</a> <span class="f1r-icon icon-14_more_small section-control"></span> <span class="f1r-icon icon-10_less_small section-control"></span> <div class="expanded-details affiliations is-hidden"> Byers Eye Institute, Stanford University School of Medicine, 2452 Watson Court, Palo Alto, CA, 94303, USA<br/> <p> <div class=margin-bottom> Matthew Powers <br/> <span>Roles: </span> Conceptualization, Data Curation, Investigation, Methodology, Writing – Original Draft Preparation, Writing – Review & Editing </div> <div class=margin-bottom> Margaret Greven <br/> <span>Roles: </span> Conceptualization, Methodology, Resources, Writing – Original Draft Preparation </div> <div class=margin-bottom> Robert Kleinman <br/> <span>Roles: </span> Conceptualization, Investigation </div> <div class=margin-bottom> Quan Dong Nguyen <br/> <span>Roles: </span> Conceptualization, Supervision, Writing – Original Draft Preparation, Writing – Review & Editing </div> <div class=margin-bottom> Diana Do <br/> <span>Roles: </span> Conceptualization, Investigation, Methodology, Resources, Supervision, Writing – Original Draft Preparation, Writing – Review & Editing </div> </p> </div> </div> </div> <div class=f1r-article-mobile> <div class="article-page-section-box margin-bottom-40 research-layout"> <span class=box-title> <span class="f1r-icon icon-85_peer_review"></span> OPEN PEER REVIEW </span> <button class="tertiary grey float-right" data-scrollto=article-reports>DETAILS</button> <div class="status-row referee-reports-container"> REVIEWER STATUS <span class=status-icons> <span class="f1r-icon icon-86_approved status-green smaller" title=Approved data-refInfo=28314-28275></span> <span class="f1r-icon icon-86_approved status-green smaller" title=Approved data-refInfo=28320-28276></span> </span> </div> </div> </div> </div> <h2 class="article-headings article-page-abstract" id=anchor-abstract> <span class="f1r-article-mobile-inline abstract-heading-border"></span> Abstract </h2> <div class="article-abstract article-page-general-text-mobile research-layout"> <div class="abstract-text is-expanded"> Despite recent advances in the diagnosis and treatment of diabetic retinopathy, this complication remains a steadfast challenge to patients and physicians. This review summarizes recent progress in the diagnosis and management of diabetic retinopathy, including automated screening, optical coherence tomography, control of systemic risk factors, surgical techniques, laser treatment, and pharmaceutical treatment, including vascular endothelial growth factor inhibitors. Recent advances in pharmaceutical treatments, in particular, hold strong promise of halting and sometimes reversing the disease process. Clinicians nevertheless must remain vigilant in their efforts to diagnose and treat this disease early in its course. </div> <div class=abstract-for-mobile> <div class="margin-top-30 padding-bottom-30 research-layout is-centered"> <button class="primary orange-text white-bg bigger-text abstract-expand-button-mobile with-border show" style="display: none;"> READ ALL <span class="f1r-icon icon-14_more_small orange vmiddle big"></span> </button> <button class="primary orange-text white-bg bigger-text abstract-expand-button-mobile with-border hide"> READ LESS <span class="f1r-icon icon-10_less_small orange vmiddle big"></span> </button> </div> </div> </div> <div class=clearfix></div> <div class="article-context no-divider"> <div class="article-abstract article-page-general-text-mobile research-layout generated-article-body"> <h2 class=main-title>Keywords</h2> <p class="u-mb--0 u-pb--2"> diabetic retinopathy, diagnosis, treatment, screening, optical coherence tomography, laser treatment, vascular endothelial growth factor inhibitors </p> </div> </div> <div class=article-information> <span class="info-separation padding-bottom"> <div id=corresponding-author-icon class="email-icon float-left"> <span class="f1r-icon icon-6_email orange"></span> <div id=corresponding-author-window class="margin-top-20 popup-window-wrapper is-hidden"> <div class="popup-window corresponding-authors-popup"> <div class=corresponding-author-container> <div class="popup-window-title small">Corresponding Author(s)</div> <div class=authors> Diana Do (<a href="mailto:dianado@stanford.edu">dianado@stanford.edu</a>) </div> </div> <div class="margin-top margin-bottom float-left"> <button id=close-popup-window class=general-white-orange-button>Close</button> </div> </div> </div> </div> <span class="icon-text float-left" data-test-id=box-corresponding-author> <b>Corresponding author:</b> Diana Do </span> <div class=clearfix></div> </span> <span class="info-separation padding-bottom competing-interests-display"> <span class=competing-interests-title>Competing interests:</span> DVD and QDN serve as consultants for Genentech and Bayer and receive research funding from Genentech and Regeneron. The other authors declare that they have no competing interests. </span> <div class="info-separation padding-bottom grant-information-display"> <span class=grant-information-title>Grant information:</span> This work was partly supported by Research to Prevent Blindness, Inc. <br/> <i>The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.</i> </div> <span class="f1r-article-desk info-separation padding-bottom"> <span class="copywrite-icon float-left"> <span class="f1r-icon icon-100_open_access"></span> </span> <span class="icon-text float-left" data-test-id=box-copyright-text> <b>Copyright:</b>&nbsp; © 2017 Powers M <em>et al</em>. This is an open access article distributed under the terms of the <a href="http://creativecommons.org/licenses/by/4.0/" target=_blank data-test-id=box-licence-link>Creative Commons Attribution License</a>, which permits unrestricted use, distribution, and reproduction in any medium, provided the original work is properly cited. </span> <div class=clearfix></div> </span> <span class="info-separation padding-bottom" data-test-id=box-how-to-cite> <b>How to cite:</b> <span class="article-title-and-info in-article-box"> Powers M, Greven M, Kleinman R <em>et al.</em> Recent advances in the management and understanding of diabetic retinopathy [version 1; peer review: 2 approved]</span>. <i>F1000Research</i> 2017, <b>6</b>(F1000 Faculty Rev):2063 (<a href="https://doi.org/10.12688/f1000research.12662.1" target=_blank>https://doi.org/10.12688/f1000research.12662.1</a>) </span> <span class=info-separation data-test-id=box-first-published><b>First published:</b> 29 Nov 2017, <b>6</b>(F1000 Faculty Rev):2063 (<a href="https://doi.org/10.12688/f1000research.12662.1" target=_blank>https://doi.org/10.12688/f1000research.12662.1</a>)</span> <span class=info-separation data-test-id=box-latest-published><b>Latest published:</b> 29 Nov 2017, <b>6</b>(F1000 Faculty Rev):2063 (<a href="https://doi.org/10.12688/f1000research.12662.1" target=_blank>https://doi.org/10.12688/f1000research.12662.1</a>)</span> </div> <div class=clearfix></div> <div id=article-context class=article-context> <div id=article1-body class=generated-article-body><h2 class=main-title id=d42381e205>Introduction</h2><p class="" id=d42381e208>Diabetic retinopathy (DR) is the leading cause of blindness among patients 25–74 years old in industrialized countries. In the US alone, there are 29 million Americans living with diabetes mellitus (DM). The diagnosis, prevention, and treatment of DR thus represent a formidable challenge to the health-care system. Vigilant awareness of the continually evolving landscape of medical knowledge is critical to stemming this crisis. This review aims to provide important clinical updates in the management of DR.</p></div><div id=article1-body class=generated-article-body><h2 class=main-title id=d42381e214>Update on diagnosis</h2><p class="" id=d42381e217>The cause of DR is multifactorial, and the primary contributor likely is chronic capillary non-perfusion and retinal ischemia. The signaling molecules insulin-like growth factor-1, platelet-derived growth factor, angiopoietin, and most importantly vascular endothelial growth factor (VEGF) all play a role in the subsequent development of microangiopathy<sup><a href="#ref-1">1</a></sup>. Recent evidence also suggests that neurodegeneration is an early event in the pathogenesis of DR<sup><a href="#ref-2">2</a>,<a href="#ref-3">3</a></sup>. From a clinical standpoint, it is clear that the primary driving factor in this pathogenesis is uncontrolled blood glucose levels, with blood pressure and blood lipid composition also playing important roles. The diagnosis of DR remains clinical in nature. The gold standard for diagnosis is a dilated eye exam and serial fundus photos. Careful attention should be given to fundoscopic features of retinopathy, including microaneurysms, intraretinal hemorrhage, hard exudates, venous beading, intraretinal microvascular anomalies (IRMAs), and, in the proliferative form, signs of neovascularization (NV). Several emerging technologies have demonstrated promise in assisting with the diagnosis of sight-threatening retinopathy. Researchers in collaboration with Google recently created a deep learning artificial neural network trained to detect retinopathy based on fundoscopic images and achieved sensitivity of 97.5–96.1% and specificity of 93.4–93.9% in detecting referable disease. In a hypothetical population with a prevalence of 8%, this translates to impressive positive and negative predictive values of 99.8% and 99.6%, respectively<sup><a href="#ref-4">4</a></sup>. Such automated systems hold the potential of offsetting the surge in demand for screening.</p></div><div id=article1-body class=generated-article-body><h2 class=main-title id=d42381e238>Update on imaging</h2><p class="" id=d42381e241>Imaging modalities, especially optical coherence tomography (OCT) and fluorescein angiography (FA), now play a crucial role in the diagnosis and management of complications of DR, particularly for diabetic macular edema (DME) and subtle NV, respectively. Newer modalities of OCT, including optical coherence tomography angiography (OCTA), hold the promise of further expanding the role of imaging. By using variation in phase and intensity of a light signal to infer vascular structures<sup><a href="#ref-5">5</a></sup>, OCTA is able to resolve vascular details not achievable by conventional FA, such as the deep and superficial capillary plexus<sup><a href="#ref-6">6</a></sup>. Several authors have argued that OCTA is at least equal to FA in terms of ability to detect macular complications of DM, as it can detect areas of IRMA and NV<sup><a href="#ref-7">7</a></sup>. Other microvascular changes seen on OCTA, specifically decreasing capillary density, branching complexity, and increasing average vascular caliber, are all associated with worsening DR (<a href="#f1">Figure 1</a>)<sup><a href="#ref-8">8</a></sup>. Intriguingly, some forms of retinal edema may be visible on OCTA but will not appear as fluid pockets on OCT or late staining on FA<sup><a href="#ref-9">9</a></sup>. Important drawbacks of the technology are the small field of view and relative deficiency in detection of microaneuryms<sup><a href="#ref-9">9</a></sup>.</p><div class="fig panel clearfix"><a name=f1 class=n-a></a><a target=_blank href="https://f1000researchdata.s3.amazonaws.com/manuscripts/13709/3172edbc-d1d9-494c-9983-768e39146065_figure1.gif"><img alt="3172edbc-d1d9-494c-9983-768e39146065_figure1.gif" src="https://f1000researchdata.s3.amazonaws.com/manuscripts/13709/3172edbc-d1d9-494c-9983-768e39146065_figure1.gif"></a><div class=caption><h3>Figure 1. Optical coherence tomography angiography image of a left eye in a patient with severe non-proliferative diabetic retinopathy, displaying enlargement and irregularity of the foveal avascular zone, and temporal capillary dropout.</h3></div></div></div><div id=article1-body class=generated-article-body><h2 class=main-title id=d42381e289>Update on glycemic control and systemic factors</h2><p class="" id=d42381e292>The Diabetes Control and Complications Trial (DCCT) and United Kingdom Prospective Diabetes Study demonstrated that glycemic control reduces microvascular complications for type 1 and type 2 diabetics, respectively<sup><a href="#ref-10">10</a></sup>. A recent 30-year follow-up of the DCCT, and more specifically the Epidemiology of Diabetes Interventions and Complications study, also showed the importance of hemoglobin A1c (HbA1c) control, revealing a 50% risk reduction of retinopathy progression in intensive glycemic control patients, despite a subsequent increase (and corresponding decreasing in standard control patients) to a mean HbA1c value of 8%<sup><a href="#ref-11">11</a>,<a href="#ref-12">12</a></sup>. The Diabetic Retinopathy Clinical Research Network (DRCR.net) recently released the results of Protocol M, which showed that the addition of personalized risk assessments and education about glycemic control during ophthalmic office visits did not affect glycemic control<sup><a href="#ref-13">13</a></sup>.</p><p class="" id=d42381e310>The Action to Control Cardiovascular Risk in Diabetes Follow-on (ACCORDION) group also recently released follow-up data of the Action to Control Cardiovascular Risk in Diabetes (ACCORD) trial. Four-year outcomes of patients with type 2 DM were compared between a standard therapy group (goal HbA1c 7.0–7.9%, mean HbA1c 7.7% during the study) and intensive glucose control group (goal HbA1c &lt;6%, mean HbA1c 6.4%). Despite normalization after the study period, only 5.8% of intensive control patients had a three-step Early Treatment Diabetic Retinopathy Study (ETDRS) worsening, compared with 12.7% of standard therapy patients<sup><a href="#ref-14">14</a></sup>. This interesting result suggests that there is a form of metabolic memory in diabetic patients, which confers a protective effect of even short periods of intense glycemic control. The ACCORDION group also looked at the effects of blood lipid composition and blood pressure, showing that intensive blood pressure control had no effect on DR progression but that treatment with fenofibrate did show a reduction in progression. The Fenofibrate on the Need for Laser Treatment for Diabetic Retinopathy (FIELD) study echoed these findings, showing that patients taking fenofibrate had a reduced need for laser therapy. Interestingly, non-lipidic mechanisms appear to have a more central role in this beneficial effect than lipidic mechanisms<sup><a href="#ref-15">15</a>,<a href="#ref-16">16</a></sup>.</p><p class="" id=d42381e324>It is important to note, however, that the ACCORD study was halted prematurely when it appeared that all-cause mortality was greater in intensive glycemic control patients. It is apparent that cardiovascular disease was the primary cause of mortality, but the exact reason for this discrepancy remains unclear. This effect was not seen in similar studies, but polypharmacy has been suggested as a possible factor<sup><a href="#ref-17">17</a></sup>. Based on the above studies, it is advisable to aim for an HbA1c of less than 7% and to avoid polypharmacy. Importantly though, glycemic goals need to be carefully individualized on the basis of the presence of additional comorbidities, expected longevity, and any other relevant factors.</p></div><div id=article1-body class=generated-article-body><h2 class=main-title id=d42381e334>Update on surgery and vitreolysis</h2><p class="" id=d42381e337>Vitreoretinal surgery is the standard treatment of several ocular complications of DR. The treatment of choice for non-clearing vitreous hemorrhage remains pars plana vitrectomy. Diabetics can experience macular edema from vitreous traction or epiretinal membranes, both of which are surgically treated. Tractional retinal detachments (TRDs) threatening the macula and combined tractional-rhegmatogenous retinal detachments should be surgically repaired<sup><a href="#ref-18">18</a></sup>, although more peripheral TRDs often can be carefully observed<sup><a href="#ref-19">19</a></sup>. Diabetic patients with vitreomacular traction (VMT) may also benefit from surgical intervention. The DRCR.net investigated the efficacy of pars plana vitrectomy and membrane peeling for patients with VMT and DME in Protocol D. The study found that nearly 40% of patients had a visual gain of at least 10 letters but that 22% had a worsening of at least 10 letters. This result was concurrent with a host of surgical complications like endophthalmitis (1.1%), vitreous hemorrhage (5.7%), and retinal detachment (3.4%)<sup><a href="#ref-20">20</a></sup>. The recent advent of small-gauge vitrectomy may help stem these complications and potentially tip the balance toward earlier surgical intervention.</p><p class="" id=d42381e352>It has been shown that the presence of a posterior vitreous detachment (PVD) reduces the risk of proliferative diabetic retinopathy (PDR) development, likely because the posterior hyaloid and vitreous act as a scaffold for NV. Ocriplasmin is a proteolytic enzyme agent intended to non-surgically induce a PVD. A trial to investigate its use in patients with diabetes is under way<sup><a href="#ref-21">21</a></sup>.</p><p class="" id=d42381e359>Non-clearing vitreous hemorrhage is a common complication of neovascular disease that is also treated surgically. The original Diabetic Retinopathy Vitrectomy Study showed that early vitrectomy (that is, within six months compared with more than one year) can be useful, especially for type 1 diabetics<sup><a href="#ref-22">22</a></sup>. Though the risks and benefits of vitrectomy must be weighed in each case, earlier surgery can be helpful in immediately restoring vision, inducing a PVD, and providing pan-retinal photocoagulation to reduce disease burden<sup><a href="#ref-23">23</a></sup>. Anti-VEGF agents have proven useful in the management of vitreous hemorrhage and have been shown to reduce the eventual need for vitrectomy<sup><a href="#ref-24">24</a></sup>. Nevertheless, vitrectomy still has a role to play for non-clearing hemorrhage.</p><p class="" id=d42381e374>Retina surgeons have also incorporated the use of intravitreal VEGF inhibitors when repairing TRDs. In case series, preoperative anti-VEGF injections have been shown to improve outcomes in patients with TRD by regressing active retinal NV and decreasing the likelihood of perioperative bleeding<sup><a href="#ref-25">25</a></sup>. However, use of these agents has also been reported to exacerbate TRDs via the ‘crunch’ phenomenon, whereby fibrovascular contraction occurs<sup><a href="#ref-26">26</a></sup>, making it more difficult to separate tissue planes<sup><a href="#ref-27">27</a></sup>. Newer techniques and devices have the potential to further improve the outcomes in patients with TRDs. Bimanual dissection techniques with chandelier lighting or an illuminated pick can be effective in repair of complex detachments and peeling membranes<sup><a href="#ref-28">28</a></sup>. Additionally, mixed-gauge vitrectomy, with 27-gauge instruments inserted through 24-gauge cannulas, can permit access to more of the retinal periphery in these complex cases<sup><a href="#ref-29">29</a></sup>.</p></div><div id=article1-body class=generated-article-body><h2 class=main-title id=d42381e401>Update on laser</h2><p class="" id=d42381e404>The landmark Diabetic Retinopathy Study demonstrated a reduction in severe vision loss in patients with high-risk PDR following prompt treatment with panretinal photocoagulation (PRP)<sup><a href="#ref-30">30</a></sup>. The ETDRS originally demonstrated a 50% reduction in moderate vision loss in patients with clinically significant diabetic macular edema (CSME) who underwent immediate focal laser photocoagulation<sup><a href="#ref-31">31</a></sup>. Moreover, among patients with PDR or severe non-proliferative diabetic retinopathy (NPDR), combined focal and scatter photocoagulation reduced severe vision loss by 50%. The DRCR.net Protocol K results revealed that among patients with a reduction in CSME 16 weeks after focal/grid laser treatment, 23–63% will continue to improve without further treatment<sup><a href="#ref-32">32</a></sup>. PRP remains a mainstay of treatment for proliferative disease. Recently, the results of DRCR.net Protocol S were released, demonstrating that the anti-VEGF agent ranibizumab was non-inferior to PRP for the treatment of PDR. At two years of follow-up, about 53% of patients in the PRP group also received intravitreal ranibizumab for coexisting DME, demonstrating that combination treatment can be helpful in these situations<sup><a href="#ref-33">33</a></sup>. How this will affect clinical practice patterns, especially in light of concerns surrounding cost and the inconvenience of regular intravitreal injections, remains to be seen. And while focal laser is still used by many practitioners, anti-VEGF agents have largely displaced it as the primary treatment of DME. There continues to be research into use of focal laser, especially in the form of non-damaging, or subthreshold, laser therapy, although to date this form has shown only marginal benefit compared with conventional laser<sup><a href="#ref-34">34</a></sup>. Although many physicians currently use non-damaging laser, there remains to be a clear consensus on its preferred use.</p></div><div id=article1-body class=generated-article-body><h2 class=main-title id=d42381e430>Update on pharmacologics: ranibizumab</h2><p class="" id=d42381e433>As mentioned previously, anti-VEGF agents are revolutionizing the management of DR. Intravitreal VEGF inhibitors are the first-line agents to treat center-involving DME, and these agents have a growing use in control of proliferative disease as well. Ranibizumab (Lucentis, Genentech, South San Francisco, CA, USA) is the antigen-binding fragment of a humanized murine recombinant monoclonal antibody to VEGF-A<sup><a href="#ref-35">35</a></sup> and is US Food and Drug Administration (FDA)-approved for the treatment of DME and DR at a dose of 0.3 mg monthly.</p><p class="" id=d42381e440>The Ranibizumab for Diabetic Macular Edema (RIDE and RISE) trials investigated the use of monthly ranibizumab at two doses—0.5 and 0.3 mg—for the treatment of DME<sup><a href="#ref-36">36</a></sup>. A secondary analysis of these data also examined the progression of DR in these patients using the diabetic retinopathy severity score (DRSS)<sup><a href="#ref-37">37</a></sup>. In patients with NPDR or PDR, there was an at least three-step improvement in 15% and 13.2% of patients using monthly 0.3 or 0.5 mg injections at 36 months, respectively<sup><a href="#ref-37">37</a></sup>. Only 3.3% of patients in the sham group achieved this result. The probabilities of progression to PDR in these patients were 39% in the sham group and 18.3% and 17.1% in the 0.3 and 0.5 mg groups, respectively.</p><p class="" id=d42381e455>Five hundred patients from RIDE and RISE were then offered ranibizumab 0.5 mg as needed, and outcomes at 48 months were examined. At 48 months, 11.2% and 7.6% of patients in the 0.3 and 0.5 mg groups achieved an at least three-step DRSS improvement, respectively. The sham with crossover group, by comparison, saw this improvement in only 4.8%. Additionally, an at least two-step worsening occurred in 2.5% and 11.3% of ranibizumab and sham patients, respectively. Finally, patients originally in the ranibizumab groups had overall lower risk of PDR development than the sham group, a finding which persisted to month 54<sup><a href="#ref-37">37</a></sup>. An additional secondary analysis looked at FA results in the sham group and showed that when these patients were switched to ranibizumab, retinal non-perfusion was halted<sup><a href="#ref-38">38</a></sup>. Overall, RIDE and RISE stressed the importance of early and regular therapy with ranibizumab.</p><p class="" id=d42381e466>The DRCR.net, mentioned above, also examined results of treatment of DME with combinations of laser, steroids, and anti-VEGF in Protocol I. The study was a prospective randomized trial which divided patients with DME into four groups: sham injection plus focal laser (L), triamcinolone injection plus focal laser (T+L), ranibizumab with prompt laser (R+pL), and ranibizumab with deferred laser (R+dL)<sup><a href="#ref-39">39</a></sup>. Further analysis then separated these groups into patients with and without PDR at the time of randomization<sup><a href="#ref-40">40</a></sup>. For patients without PDR at baseline, worsening of retinopathy at 36 months was reported in 7%, 18%, 23%, and 37% of R+dL, R+pL, L, and T+L groups, respectively. Among patients with PDR at baseline, worsening of retinopathy at 36 months was reported in 18%, 21%, 40%, and 12% among the same respective groups. Additionally, patients receiving injections of any kind (ranibizumab or triamcinolone) had lower rates of vitreous hemorrhage and were less likely to require PRP. The results are strong evidence that ranibizumab can help prevent progression of retinopathy.</p><p class="" id=d42381e478>As mentioned previously, DRCR.net Protocol S also showed that ranibizumab was non-inferior to PRP in patients with high-risk PDR<sup><a href="#ref-33">33</a></sup>. Additional 2016 data showed that patients with PDR treated with ranibizumab showed less progression than patients treated with PRP<sup><a href="#ref-41">41</a></sup>. Ranibizumab was recently approved by the FDA for treatment of all forms of DR. It remains to be seen how the results of Protocol S combined with this approval will affect clinical practice patterns.</p></div><div id=article1-body class=generated-article-body><h2 class=main-title id=d42381e492>Update on pharmacologics: aflibercept</h2><p class="" id=d42381e495>Aflibercept (Eylea, Regeneron, Tarrytown, NY, USA), another widely used agent, is a fusion protein of the human IgG Fc region and the extracellular VEGF receptor ligand binding region, which binds to VEGF-A, VEGF-B, placental growth factor-1 (PlGF-1), and PlGF-2<sup><a href="#ref-35">35</a></sup>. It is FDA-approved for the treatment of DME and DR in patients with DME at a dose of 2 mg every eight weeks after five initial monthly injections. It has been studied recently in the Intravitreal Aflibercept for Diabetic Macular Edema (VISTA and VIVID) trials. In these trials, aflibercept was compared with focal laser for the treatment of DME<sup><a href="#ref-42">42</a></sup>. These studies demonstrated the superiority of aflibercept over laser in terms of visual acuity improvement and at least two-step improvement in DRSS. Patients were separated 1:1:1 into groups receiving focal laser, 2 mg of intravitreal aflibercept every four weeks, or 2 mg every eight weeks. Both injection groups initially received five months of monthly aflibercept injections. Patients in either aflibercept group were three times more likely to achieve at least two-step DRSS improvement than patients in the laser group. In both studies, baseline DRSS was correlated with the likelihood of at least two-step DRSS improvement.</p><p class="" id=d42381e506>A recent publication from the DRCR.net<sup><a href="#ref-43">43</a></sup> evaluated eyes enrolled in Protocol T and reviewed how their DRSS changed after treatment with aflibercept, bevacizumab, or ranibizumab. In this analysis, all three agents were effective in reducing DR. However, in the subset of eyes that had PDR at baseline, aflibercept was more effective in regressing the PDR than bevacizumab or ranibizumab.</p></div><div id=article1-body class=generated-article-body><h2 class=main-title id=d42381e516>Update on pharmacologics: bevacizumab</h2><p class="" id=d42381e519>Bevacizumab (Avastin, Genentech) is a full-length humanized murine monoclonal antibody that binds to VEGF-A<sup><a href="#ref-35">35</a></sup>. It is not FDA-approved for the treatment of DR or DME. The intravitreal bevacizumab or laser therapy in the management of diabetic macular edema (BOLT) study examined the efficacy of bevacizumab versus focal laser for DME. Patients in the bevacizumab group showed significant best-corrected visual acuity (BCVA) improvement over patients in the laser group<sup><a href="#ref-44">44</a></sup>. ETDRS retinopathy levels were also included and showed that patients in the bevacizumab arm trended toward DR reduction, although this effect was not statistically significant. This is likely due to the relatively small number of patients enrolled in the study. A recent comparative effectiveness randomized clinical trial conducted by the DRCR.net compared bevacizumab with ranibizumab and aflibercept for DME and found that all three agents are effective treatments, and this was confirmed on two-year follow-up<sup><a href="#ref-45">45</a></sup>.</p></div><div id=article1-body class=generated-article-body><h2 class=main-title id=d42381e537>Anti–vascular endothelial growth factor summary</h2><p class="" id=d42381e540>These and earlier trials of anti-VEGF agents are evidence that early and regular anti-VEGF treatment can halt and sometimes reverse DR. The reason for reversal is still unclear, and elucidation of this mechanism may open the door to new therapies. Given that capillary non-perfusion and retinal ischemia may be the primary contributors to DME and DR progression at baseline, it is possible that halting non-perfusion results in a reversal of the disease in some patients<sup><a href="#ref-37">37</a></sup>. Knowing which patients will or will not benefit most from anti-VEGF treatment continues be an active area of research. It has been suggested that early positive response to anti-VEGF injections predicts outcome at three months<sup><a href="#ref-46">46</a></sup>. Conversely, recent OCTA data showed that deep capillary plexus damage predicts poor response to treatment<sup><a href="#ref-47">47</a></sup>. As with any invasive therapy, careful consideration of the risks and benefits of repeated intravitreal injections is necessary for each patient. These risks include serious ophthalmic complications such as endophthalmitis and retinal detachment as well as potential systemic complications such as hypertension, proteinuria, impaired wound healing, and increased risk of cardiovascular events<sup><a href="#ref-48">48</a></sup>.</p></div><div id=article1-body class=generated-article-body><h2 class=main-title id=d42381e562>Update on dexamethasone and fluocinolone acetonide</h2><p class="" id=d42381e565>Despite the dominance of anti-VEGF agents, there is still a role to play for intravitreal corticosteroids. Steroids work by inhibiting leukostasis, enhancing barrier function of tight junctions, and mitigating release of local inflammatory factors, including VEGF<sup><a href="#ref-49">49</a></sup>. The Macular Edema: Assessment of Implantable Dexamethasone in Diabetes (MEAD) study examined the effectiveness of a dexamethasone implant versus sham for the treatment of DME. The implant groups (0.7 and 0.35 mg) had higher percentages of patients achieving at least 15 ETDRS letters gained at 3-year follow-up compared with the sham group (22%, 18%, and 12%, respectively). A pooled analysis of the MEAD study showed that patients in either implant group had a 12-month delay in two-step DR progression (36 versus 24 months) compared with sham patients<sup><a href="#ref-50">50</a></sup>. As with most steroid treatments, development of cataract and intraocular pressure (IOP) elevation were the most common side effects.</p><p class="" id=d42381e576>Fluocinolone acetonide (Iluvien, Alimera Sciences, Alpharetta, GA, USA) is another corticosteroid implant that has treatment benefit for at least three years. The Fluocinolone Acetonide in Diabetic Macular Edema study evaluated low-dose (0.2 μg per day) and high-dose (0.5 μg per day) fluocinolone implants in patients with DME who had received at least one laser treatment. At 36 months, 33% and 31.9% of patients in the low-dose and high-dose groups, respectively, had an improvement of 15 ETDRS letters or more, compared with 21.4% of sham patients. Of patients with a history of DME at least three years, 34% and 28.8% of low- and high-dose patients, respectively, gained 15 ETDRS letters or more, compared with 13.4% of sham patients. Moreover, an at least two-step improvement in DRSS occurred in 13.7% of low-dose and 10.1% of high-dose patients compared with 8.9% of sham patients. As with other steroid therapies, side effects included cataract and IOP elevation. IOP elevation was severe enough to require glaucoma tube shunt placement in less than 5% of low-dose patients and 8% of high-dose patients<sup><a href="#ref-51">51</a></sup>.</p><p class="" id=d42381e583>The results of DRCR Protocol U will also soon be available. This study will assess the short-term effects of combination intravitreal dexamethasone and ranibizumab therapy in eyes with persistent DME despite prior anti-VEGF therapy compared with continued anti-VEGF therapy alone.</p></div><div id=article1-body class=generated-article-body><h2 class=main-title id=d42381e590>Summary of pharmacologic agents</h2><p class="" id=d42381e593>The continued takeaway of these recent studies on pharmacologic agents is that early treatment of DME in NPDR or PDR is vital to halt and sometimes reverse retinopathy. De-escalation of anti-VEGF treatment is sometimes possible without compromising initial gains, although this is more often the case when therapy has been initiated early. Corticosteroids are beginning to take a place as second-line therapy for patients unresponsive to anti-VEGF agents or focal laser or both. This is especially applicable for pseudophakic patients who have passed a steroid IOP challenge.</p></div><div id=article1-body class=generated-article-body><h2 class=main-title id=d42381e599>Conclusions</h2><p class="" id=d42381e602>Despite the remarkable gains we have made in the treatment of DR and its complications, the primary strategy against this disease should be the ardent prevention of diabetes whenever possible. If diabetes is already present, tight glycemic control is the most important modality to prevent or control retinopathy, and control of other systemic factors such as lipid levels and blood pressure also plays an important role. New diagnostic approaches and imaging modalities may aid in capturing referable retinopathy at earlier stages. Once retinopathy develops, early and regular treatment is crucial to prevent permanent vision loss. While there remains a place for laser and incisional surgery, the role of pharmaceutical agents has expanded in recent years. Anti-VEGF agents have become the first-line agents for the treatment of center-involved DME. In addition, intravitreal VEGF inhibitors have been proven to be effective in regressing DR. Inhibition of VEGF has resulted in an effective treatment to preserve vision in patients with DR. Future treatment strategies might focus on less invasive delivery methods or alternative therapeutic targets. In the early stages of DR, when neurodegeneration plays an important role, intravitreal anti-VEGF injections may represent an overly aggressive approach. In these situations, topically delivered therapies, such as endogenous neuroprotective substances, hold exciting promise<sup><a href="#ref-52">52</a></sup>. Along with the continued vigilance of clinicians, the expanding armamentarium of diagnostic and therapeutic options for DR will be an invaluable tool in the fight to reduce the impact of this devastating disease.</p></div><div id=article1-back class=generated-article-footer><div class=back-section><a name=d42381e1 class=n-a></a><h2 class=main-title id=d42533>Competing interests</h2><p class=metadata-entry><a name=d42381e136 class=n-a></a><p id=d42381e137> DVD and QDN serve as consultants for Genentech and Bayer and receive research funding from Genentech and Regeneron. The other authors declare that they have no competing interests. </p></p></div><div class=back-section><a name=d42381e1 class=n-a></a><h2 class=main-title id=d42535>Grant information</h2><p>This work was partly supported by Research to Prevent Blindness, Inc.</p><p> <i>The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript</i> </p></div><div class=back-section><a name=d42381e613 class=n-a></a><span class="research-layout prime-recommended-wrapper reference-heading"><span class="f1r-icon icon-79_faculty_recommended_badge red vmiddle default-cursor"></span><span class="prime-red big">F1000 recommended</span></span><h2 class=main-title id=d42709>References</h2><div class="section ref-list"><a name=d42381e613 class=n-a></a><ul><li><a name=ref-1 class=n-a></a><span class=label>1. </span>&nbsp;<span class=citation><a target=_blank title="F1000 recommended" class="research-layout prime-recommended-reference" href="https://f1000.com/prime/725482723"><span class="f1r-icon icon-79_faculty_recommended_badge small red vmiddle"></span></a><a name=d42381e620 class=n-a></a>Simó R, Hernández C: Novel approaches for treating diabetic retinopathy based on recent pathogenic evidence. <i>Prog Retin Eye Res.</i> 2015; <b>48</b>: 160–80. <a target=xrefwindow id=d42381e628 href="http://www.ncbi.nlm.nih.gov/pubmed/25936649">PubMed Abstract </a> | <a target=xrefwindow id=d42381e631 href="http://dx.doi.org/10.1016/j.preteyeres.2015.04.003">Publisher Full Text </a> | <a target=_blank title="F1000 recommended" href="https://f1000.com/prime/725482723">F1000 Recommendation</a></span></li><li><a name=ref-2 class=n-a></a><span class=label>2. </span>&nbsp;<span class=citation><a name=d42381e644 class=n-a></a>Stem MS, Gardner TW: Neurodegeneration in the pathogenesis of diabetic retinopathy: molecular mechanisms and therapeutic implications. <i>Curr Med Chem.</i> 2013; <b>20</b>(26): 3241–50. <a target=xrefwindow id=d42381e652 href="http://www.ncbi.nlm.nih.gov/pubmed/23745549">PubMed Abstract </a> | <a target=xrefwindow id=d42381e655 href="http://dx.doi.org/10.2174/09298673113209990027">Publisher Full Text </a> | <a target=xrefwindow id=d42381e658 href="http://www.ncbi.nlm.nih.gov/pmc/articles/4071765">Free Full Text </a></span></li><li><a name=ref-3 class=n-a></a><span class=label>3. </span>&nbsp;<span class=citation><a name=d42381e667 class=n-a></a>Simó R, Hernández C, European Consortium for the Early Treatment of Diabetic Retinopathy (EUROCONDOR): Neurodegeneration in the diabetic eye: new insights and therapeutic perspectives. <i>Trends Endocrinol Metab.</i> 2014; <b>25</b>(1): 23–33. <a target=xrefwindow id=d42381e675 href="http://www.ncbi.nlm.nih.gov/pubmed/24183659">PubMed Abstract </a> | <a target=xrefwindow id=d42381e678 href="http://dx.doi.org/10.1016/j.tem.2013.09.005">Publisher Full Text </a></span></li><li><a name=ref-4 class=n-a></a><span class=label>4. </span>&nbsp;<span class=citation><a target=_blank title="F1000 recommended" class="research-layout prime-recommended-reference" href="https://f1000.com/prime/727037150"><span class="f1r-icon icon-79_faculty_recommended_badge small red vmiddle"></span></a><a name=d42381e687 class=n-a></a>Gulshan V, Peng L, Coram M, <i> et al.</i>: Development and Validation of a Deep Learning Algorithm for Detection of Diabetic Retinopathy in Retinal Fundus Photographs. <i>JAMA.</i> 2016; <b>316</b>(22): 2402–10. <a target=xrefwindow id=d42381e698 href="http://www.ncbi.nlm.nih.gov/pubmed/27898976">PubMed Abstract </a> | <a target=xrefwindow id=d42381e701 href="http://dx.doi.org/10.1001/jama.2016.17216">Publisher Full Text </a> | <a target=_blank title="F1000 recommended" href="https://f1000.com/prime/727037150">F1000 Recommendation</a></span></li><li><a name=ref-5 class=n-a></a><span class=label>5. </span>&nbsp;<span class=citation><a name=d42381e714 class=n-a></a>An L, Wang RK: Volumetric imaging of microcirculations in human retina and choroids <i>in vivo</i> by optical micro-angiography. In: Tuchin VV, Wang LV, editors. San Jose, CA: SPIE; 2008; 68550A. <a target=xrefwindow id=d42381e719 href="http://dx.doi.org/10.1117/12.769085">Publisher Full Text </a></span></li><li><a name=ref-6 class=n-a></a><span class=label>6. </span>&nbsp;<span class=citation><a target=_blank title="F1000 recommended" class="research-layout prime-recommended-reference" href="https://f1000.com/prime/725419024"><span class="f1r-icon icon-79_faculty_recommended_badge small red vmiddle"></span></a><a name=d42381e729 class=n-a></a>Spaide RF, Klancnik JM Jr, Cooney MJ: Retinal vascular layers imaged by fluorescein angiography and optical coherence tomography angiography. <i>JAMA Ophthalmol.</i> 2015; <b>133</b>(1): 45–50. <a target=xrefwindow id=d42381e737 href="http://www.ncbi.nlm.nih.gov/pubmed/25317632">PubMed Abstract </a> | <a target=xrefwindow id=d42381e740 href="http://dx.doi.org/10.1001/jamaophthalmol.2014.3616">Publisher Full Text </a> | <a target=_blank title="F1000 recommended" href="https://f1000.com/prime/725419024">F1000 Recommendation</a></span></li><li><a name=ref-7 class=n-a></a><span class=label>7. </span>&nbsp;<span class=citation><a target=_blank title="F1000 recommended" class="research-layout prime-recommended-reference" href="https://f1000.com/prime/725442818"><span class="f1r-icon icon-79_faculty_recommended_badge small red vmiddle"></span></a><a name=d42381e753 class=n-a></a>Ishibazawa A, Nagaoka T, Takahashi A, <i> et al.</i>: Optical Coherence Tomography Angiography in Diabetic Retinopathy: A Prospective Pilot Study. <i>Am J Ophthalmol.</i> 2015; <b>160</b>(1): 35–44.e1. <a target=xrefwindow id=d42381e764 href="http://www.ncbi.nlm.nih.gov/pubmed/25896459">PubMed Abstract </a> | <a target=xrefwindow id=d42381e767 href="http://dx.doi.org/10.1016/j.ajo.2015.04.021">Publisher Full Text </a> | <a target=_blank title="F1000 recommended" href="https://f1000.com/prime/725442818">F1000 Recommendation</a></span></li><li><a name=ref-8 class=n-a></a><span class=label>8. </span>&nbsp;<span class=citation><a target=_blank title="F1000 recommended" class="research-layout prime-recommended-reference" href="https://f1000.com/prime/726502708"><span class="f1r-icon icon-79_faculty_recommended_badge small red vmiddle"></span></a><a name=d42381e780 class=n-a></a>Kim AY, Chu Z, Shahidzadeh A, <i> et al.</i>: Quantifying Microvascular Density and Morphology in Diabetic Retinopathy Using Spectral-Domain Optical Coherence Tomography Angiography. <i>Invest Ophthalmol Vis Sci.</i> 2016; <b>57</b>(9): OCT362–70. <a target=xrefwindow id=d42381e791 href="http://www.ncbi.nlm.nih.gov/pubmed/27409494">PubMed Abstract </a> | <a target=xrefwindow id=d42381e794 href="http://dx.doi.org/10.1167/iovs.15-18904">Publisher Full Text </a> | <a target=xrefwindow id=d42381e798 href="http://www.ncbi.nlm.nih.gov/pmc/articles/4968771">Free Full Text </a> | <a target=_blank title="F1000 recommended" href="https://f1000.com/prime/726502708">F1000 Recommendation</a></span></li><li><a name=ref-9 class=n-a></a><span class=label>9. </span>&nbsp;<span class=citation><a target=_blank title="F1000 recommended" class="research-layout prime-recommended-reference" href="https://f1000.com/prime/732135367"><span class="f1r-icon icon-79_faculty_recommended_badge small red vmiddle"></span></a><a name=d42381e811 class=n-a></a>Matsunaga DR, Yi JJ, De Koo LO, <i> et al.</i>: Optical Coherence Tomography Angiography of Diabetic Retinopathy in Human Subjects. <i>Ophthalmic Surg Lasers Imaging Retina.</i> 2015; <b>46</b>(8): 796–805. <a target=xrefwindow id=d42381e822 href="http://www.ncbi.nlm.nih.gov/pubmed/26431294">PubMed Abstract </a> | <a target=xrefwindow id=d42381e825 href="http://dx.doi.org/10.3928/23258160-20150909-03">Publisher Full Text </a> | <a target=_blank title="F1000 recommended" href="https://f1000.com/prime/732135367">F1000 Recommendation</a></span></li><li><a name=ref-10 class=n-a></a><span class=label>10. </span>&nbsp;<span class=citation><a name=d42381e838 class=n-a></a>Intensive blood-glucose control with sulphonylureas or insulin compared with conventional treatment and risk of complications in patients with type 2 diabetes (UKPDS 33). UK Prospective Diabetes Study (UKPDS) Group. <i>Lancet.</i> 1998; <b>352</b>(9131): 837–53. <a target=xrefwindow id=d42381e846 href="http://www.ncbi.nlm.nih.gov/pubmed/9742976">PubMed Abstract </a> | <a target=xrefwindow id=d42381e849 href="http://dx.doi.org/10.1016/S0140-6736(98)07019-6">Publisher Full Text </a></span></li><li><a name=ref-11 class=n-a></a><span class=label>11. </span>&nbsp;<span class=citation><a target=_blank title="F1000 recommended" class="research-layout prime-recommended-reference" href="https://f1000.com/prime/1161289"><span class="f1r-icon icon-79_faculty_recommended_badge small red vmiddle"></span></a><a name=d42381e858 class=n-a></a>Holman RR, Paul SK, Bethel MA, <i> et al.</i>: 10-year follow-up of intensive glucose control in type 2 diabetes. <i>N Engl J Med.</i> 2008; <b>359</b>(15): 1577–89. <a target=xrefwindow id=d42381e869 href="http://www.ncbi.nlm.nih.gov/pubmed/18784090">PubMed Abstract </a> | <a target=xrefwindow id=d42381e872 href="http://dx.doi.org/10.1056/NEJMoa0806470">Publisher Full Text </a> | <a target=_blank title="F1000 recommended" href="https://f1000.com/prime/1161289">F1000 Recommendation</a></span></li><li><a name=ref-12 class=n-a></a><span class=label>12. </span>&nbsp;<span class=citation><a target=_blank title="F1000 recommended" class="research-layout prime-recommended-reference" href="https://f1000.com/prime/718233254"><span class="f1r-icon icon-79_faculty_recommended_badge small red vmiddle"></span></a><a name=d42381e886 class=n-a></a>Nathan DM, Bayless M, Cleary P, <i> et al.</i>: Diabetes control and complications trial/epidemiology of diabetes interventions and complications study at 30 years: advances and contributions. <i>Diabetes.</i> 2013; <b>62</b>(12): 3976–86. <a target=xrefwindow id=d42381e897 href="http://www.ncbi.nlm.nih.gov/pubmed/24264395">PubMed Abstract </a> | <a target=xrefwindow id=d42381e900 href="http://dx.doi.org/10.2337/db13-1093">Publisher Full Text </a> | <a target=xrefwindow id=d42381e904 href="http://www.ncbi.nlm.nih.gov/pmc/articles/3837056">Free Full Text </a> | <a target=_blank title="F1000 recommended" href="https://f1000.com/prime/718233254">F1000 Recommendation</a></span></li><li><a name=ref-13 class=n-a></a><span class=label>13. </span>&nbsp;<span class=citation><a target=_blank title="F1000 recommended" class="research-layout prime-recommended-reference" href="https://f1000.com/prime/730625915"><span class="f1r-icon icon-79_faculty_recommended_badge small red vmiddle"></span></a><a name=d42381e917 class=n-a></a>Aiello LP, Ayala AR, Antoszyk AN, <i> et al.</i>: Assessing the Effect of Personalized Diabetes Risk Assessments During Ophthalmologic Visits on Glycemic Control: A Randomized Clinical Trial. <i>JAMA Ophthalmol.</i> 2015; <b>133</b>(8): 888–96. <a target=xrefwindow id=d42381e928 href="http://www.ncbi.nlm.nih.gov/pubmed/25996273">PubMed Abstract </a> | <a target=xrefwindow id=d42381e931 href="http://dx.doi.org/10.1001/jamaophthalmol.2015.1312">Publisher Full Text </a> | <a target=xrefwindow id=d42381e935 href="http://www.ncbi.nlm.nih.gov/pmc/articles/4924347">Free Full Text </a> | <a target=_blank title="F1000 recommended" href="https://f1000.com/prime/730625915">F1000 Recommendation</a></span></li><li><a name=ref-14 class=n-a></a><span class=label>14. </span>&nbsp;<span class=citation><a target=_blank title="F1000 recommended" class="research-layout prime-recommended-reference" href="https://f1000.com/prime/726416289"><span class="f1r-icon icon-79_faculty_recommended_badge small red vmiddle"></span></a><a name=d42381e948 class=n-a></a>Action to Control Cardiovascular Risk in Diabetes Follow-On (ACCORDION) Eye Study Group and the Action to Control Cardiovascular Risk in Diabetes Follow-On (ACCORDION) Study Group: Persistent Effects of Intensive Glycemic Control on Retinopathy in Type 2 Diabetes in the Action to Control Cardiovascular Risk in Diabetes (ACCORD) Follow-On Study. <i>Diabetes Care.</i> 2016; <b>39</b>(7): 1089–100. <a target=xrefwindow id=d42381e956 href="http://www.ncbi.nlm.nih.gov/pubmed/27289122">PubMed Abstract </a> | <a target=xrefwindow id=d42381e959 href="http://dx.doi.org/10.2337/dc16-0024">Publisher Full Text </a> | <a target=xrefwindow id=d42381e962 href="http://www.ncbi.nlm.nih.gov/pmc/articles/4915557">Free Full Text </a> | <a target=_blank title="F1000 recommended" href="https://f1000.com/prime/726416289">F1000 Recommendation</a></span></li><li><a name=ref-15 class=n-a></a><span class=label>15. </span>&nbsp;<span class=citation><a name=d42381e975 class=n-a></a>Keech AC, Mitchell P, Summanen PA, <i> et al.</i>: Effect of fenofibrate on the need for laser treatment for diabetic retinopathy (FIELD study): a randomised controlled trial. <i>Lancet.</i> 2007; <b>370</b>(9600): 1687–97. <a target=xrefwindow id=d42381e986 href="http://www.ncbi.nlm.nih.gov/pubmed/17988728">PubMed Abstract </a> | <a target=xrefwindow id=d42381e989 href="http://dx.doi.org/10.1016/S0140-6736(07)61607-9">Publisher Full Text </a></span></li><li><a name=ref-16 class=n-a></a><span class=label>16. </span>&nbsp;<span class=citation><a name=d42381e998 class=n-a></a>Simó R, Roy S, Behar-Cohen F, <i> et al.</i>: Fenofibrate: a new treatment for diabetic retinopathy. Molecular mechanisms and future perspectives. <i>Curr Med Chem.</i> 2013; <b>20</b>(26): 3258–66. <a target=xrefwindow id=d42381e1009 href="http://www.ncbi.nlm.nih.gov/pubmed/23745548">PubMed Abstract </a> | <a target=xrefwindow id=d42381e1012 href="http://dx.doi.org/10.2174/0929867311320260009">Publisher Full Text </a></span></li><li><a name=ref-17 class=n-a></a><span class=label>17. </span>&nbsp;<span class=citation><a target=_blank title="F1000 recommended" class="research-layout prime-recommended-reference" href="https://f1000.com/prime/732135369"><span class="f1r-icon icon-79_faculty_recommended_badge small red vmiddle"></span></a><a name=d42381e1021 class=n-a></a>Ferris FL 3rd, Nathan DM: Preventing Diabetic Retinopathy Progression. <i>Ophthalmology.</i> 2016; <b>123</b>(9): 1840–2. <a target=xrefwindow id=d42381e1029 href="http://www.ncbi.nlm.nih.gov/pubmed/27549874">PubMed Abstract </a> | <a target=xrefwindow id=d42381e1032 href="http://dx.doi.org/10.1016/j.ophtha.2016.05.039">Publisher Full Text </a> | <a target=_blank title="F1000 recommended" href="https://f1000.com/prime/732135369">F1000 Recommendation</a></span></li><li><a name=ref-18 class=n-a></a><span class=label>18. </span>&nbsp;<span class=citation><a name=d42381e1046 class=n-a></a>Aaberg TM: Pars plana vitrectomy for diabetic traction retinal detachment. <i>Ophthalmology.</i> 1981; <b>88</b>(7): 639–42. <a target=xrefwindow id=d42381e1054 href="http://www.ncbi.nlm.nih.gov/pubmed/7267031">PubMed Abstract </a> | <a target=xrefwindow id=d42381e1057 href="http://dx.doi.org/10.1016/S0161-6420(81)34973-2">Publisher Full Text </a></span></li><li><a name=ref-19 class=n-a></a><span class=label>19. </span>&nbsp;<span class=citation><a name=d42381e1066 class=n-a></a>Charles S, Flinn CE: The natural history of diabetic extramacular traction retinal detachment. <i>Arch Ophthalmol.</i> 1981; <b>99</b>(1): 66–8. <a target=xrefwindow id=d42381e1074 href="http://www.ncbi.nlm.nih.gov/pubmed/7458741">PubMed Abstract </a> | <a target=xrefwindow id=d42381e1077 href="http://dx.doi.org/10.1001/archopht.1981.03930010068003">Publisher Full Text </a></span></li><li><a name=ref-20 class=n-a></a><span class=label>20. </span>&nbsp;<span class=citation><a name=d42381e1086 class=n-a></a>Diabetic Retinopathy Clinical Research Network Writing Committee, Haller JA, Qin H, <i> et al.</i>: Vitrectomy outcomes in eyes with diabetic macular edema and vitreomacular traction. <i>Ophthalmology.</i> 2010; <b>117</b>(6): 1087–1093.e3. <a target=xrefwindow id=d42381e1097 href="http://www.ncbi.nlm.nih.gov/pubmed/20299105">PubMed Abstract </a> | <a target=xrefwindow id=d42381e1100 href="http://dx.doi.org/10.1016/j.ophtha.2009.10.040">Publisher Full Text </a> | <a target=xrefwindow id=d42381e1104 href="http://www.ncbi.nlm.nih.gov/pmc/articles/2911350">Free Full Text </a></span></li><li><a name=ref-21 class=n-a></a><span class=label>21. </span>&nbsp;<span class=citation><a name=d42381e1113 class=n-a></a>Khoshnevis M, Sebag J: Pharmacologic vitreolysis with ocriplasmin: rationale for use and therapeutic potential in vitreo-retinal disorders. <i>BioDrugs.</i> 2015; <b>29</b>(2): 103–12. <a target=xrefwindow id=d42381e1121 href="http://www.ncbi.nlm.nih.gov/pubmed/25812991">PubMed Abstract </a> | <a target=xrefwindow id=d42381e1124 href="http://dx.doi.org/10.1007/s40259-015-0120-y">Publisher Full Text </a></span></li><li><a name=ref-22 class=n-a></a><span class=label>22. </span>&nbsp;<span class=citation><a name=d42381e1133 class=n-a></a>Early vitrectomy for severe vitreous hemorrhage in diabetic retinopathy. Two-year results of a randomized trial. Diabetic Retinopathy Vitrectomy Study report 2. The Diabetic Retinopathy Vitrectomy Study Research Group. <i>Arch Ophthalmol.</i> 1985; <b>103</b>(11): 1644–52. <a target=xrefwindow id=d42381e1141 href="http://www.ncbi.nlm.nih.gov/pubmed/2865943">PubMed Abstract </a> | <a target=xrefwindow id=d42381e1144 href="http://dx.doi.org/10.1001/archopht.1985.01050110038020">Publisher Full Text </a></span></li><li><a name=ref-23 class=n-a></a><span class=label>23. </span>&nbsp;<span class=citation><a name=d42381e1153 class=n-a></a>Early vitrectomy for severe proliferative diabetic retinopathy in eyes with useful vision. Results of a randomized trial--Diabetic Retinopathy Vitrectomy Study Report 3. The Diabetic Retinopathy Vitrectomy Study Research Group. <i>Ophthalmology.</i> 1988; <b>95</b>(10): 1307–20. <a target=xrefwindow id=d42381e1161 href="http://www.ncbi.nlm.nih.gov/pubmed/2465517">PubMed Abstract </a> | <a target=xrefwindow id=d42381e1164 href="http://dx.doi.org/10.1016/S0161-6420(88)33015-0">Publisher Full Text </a></span></li><li><a name=ref-24 class=n-a></a><span class=label>24. </span>&nbsp;<span class=citation><a target=_blank title="F1000 recommended" class="research-layout prime-recommended-reference" href="https://f1000.com/prime/727600949"><span class="f1r-icon icon-79_faculty_recommended_badge small red vmiddle"></span></a><a name=d42381e1174 class=n-a></a>Chelala E, Nehme J, El Rami H, <i> et al.</i>: Efficacy Of Intravitreal Ranibizumab Injections In The Treatment Of Vitreous Hemorrhage Related To Proliferative Diabetic Retinopathy. <i>Retina.</i> 2017. <a target=xrefwindow id=d42381e1182 href="http://www.ncbi.nlm.nih.gov/pubmed/28489694">PubMed Abstract </a> | <a target=xrefwindow id=d42381e1185 href="http://dx.doi.org/10.1097/IAE.0000000000001673">Publisher Full Text </a> | <a target=_blank title="F1000 recommended" href="https://f1000.com/prime/727600949">F1000 Recommendation</a></span></li><li><a name=ref-25 class=n-a></a><span class=label>25. </span>&nbsp;<span class=citation><a name=d42381e1198 class=n-a></a>di Lauro R, De Ruggiero P, di Lauro R, <i> et al.</i>: Intravitreal bevacizumab for surgical treatment of severe proliferative diabetic retinopathy. <i>Graefes Arch Clin Exp Ophthalmol.</i> 2010; <b>248</b>(6): 785–91. <a target=xrefwindow id=d42381e1209 href="http://www.ncbi.nlm.nih.gov/pubmed/20135139">PubMed Abstract </a> | <a target=xrefwindow id=d42381e1212 href="http://dx.doi.org/10.1007/s00417-010-1303-3">Publisher Full Text </a></span></li><li><a name=ref-26 class=n-a></a><span class=label>26. </span>&nbsp;<span class=citation><a name=d42381e1221 class=n-a></a>Arevalo JF, Maia M, Flynn HW Jr, <i> et al.</i>: Tractional retinal detachment following intravitreal bevacizumab (Avastin) in patients with severe proliferative diabetic retinopathy. <i>Br J Ophthalmol.</i> 2008; <b>92</b>(2): 213–6. <a target=xrefwindow id=d42381e1232 href="http://www.ncbi.nlm.nih.gov/pubmed/17965108">PubMed Abstract </a> | <a target=xrefwindow id=d42381e1235 href="http://dx.doi.org/10.1136/bjo.2007.127142">Publisher Full Text </a></span></li><li><a name=ref-27 class=n-a></a><span class=label>27. </span>&nbsp;<span class=citation><a name=d42381e1244 class=n-a></a>Oellers P, Mahmoud TH: Surgery for Proliferative Diabetic Retinopathy: New Tips and Tricks. <i>J Ophthalmic Vis Res.</i> 2016; <b>11</b>(1): 93–9. <a target=xrefwindow id=d42381e1252 href="http://www.ncbi.nlm.nih.gov/pubmed/27195092">PubMed Abstract </a> | <a target=xrefwindow id=d42381e1255 href="http://dx.doi.org/10.4103/2008-322X.180697">Publisher Full Text </a> | <a target=xrefwindow id=d42381e1258 href="http://www.ncbi.nlm.nih.gov/pmc/articles/4860995">Free Full Text </a></span></li><li><a name=ref-28 class=n-a></a><span class=label>28. </span>&nbsp;<span class=citation><a name=d42381e1267 class=n-a></a>Sharma S, Hariprasad SM, Mahmoud TH: Surgical management of proliferative diabetic retinopathy. <i>Ophthalmic Surg Lasers Imaging Retina.</i> 2014; <b>45</b>(3): 188–93. <a target=xrefwindow id=d42381e1275 href="http://www.ncbi.nlm.nih.gov/pubmed/24840530">PubMed Abstract </a> | <a target=xrefwindow id=d42381e1278 href="http://dx.doi.org/10.3928/23258160-20140505-01">Publisher Full Text </a></span></li><li><a name=ref-29 class=n-a></a><span class=label>29. </span>&nbsp;<span class=citation><a name=d42381e1287 class=n-a></a>Walter SD, Mahmoud TH: Hybrid-gauge and Mixed-gauge Microincisional Vitrectomy Surgery. <i>Int Ophthalmol Clin.</i> 2016; <b>56</b>(4): 85–95. <a target=xrefwindow id=d42381e1295 href="http://www.ncbi.nlm.nih.gov/pubmed/27575760">PubMed Abstract </a> | <a target=xrefwindow id=d42381e1298 href="http://dx.doi.org/10.1097/IIO.0000000000000141">Publisher Full Text </a></span></li><li><a name=ref-30 class=n-a></a><span class=label>30. </span>&nbsp;<span class=citation><a name=d42381e1308 class=n-a></a>Preliminary report on effects of photocoagulation therapy. The Diabetic Retinopathy Study Research Group. <i>Am J Ophthalmol.</i> 1976; <b>81</b>(4): 383–96. <a target=xrefwindow id=d42381e1316 href="http://www.ncbi.nlm.nih.gov/pubmed/944535">PubMed Abstract </a> | <a target=xrefwindow id=d42381e1319 href="http://dx.doi.org/10.1016/0002-9394(76)90292-0">Publisher Full Text </a></span></li><li><a name=ref-31 class=n-a></a><span class=label>31. </span>&nbsp;<span class=citation><a name=d42381e1328 class=n-a></a>Photocoagulation for diabetic macular edema. Early Treatment Diabetic Retinopathy Study report number 1. Early Treatment Diabetic Retinopathy Study research group. <i>Arch Ophthalmol.</i> 1985; <b>103</b>(12): 1796–806. <a target=xrefwindow id=d42381e1336 href="http://www.ncbi.nlm.nih.gov/pubmed/2866759">PubMed Abstract </a> | <a target=xrefwindow id=d42381e1339 href="http://dx.doi.org/10.1001/archopht.1985.01050120030015">Publisher Full Text </a></span></li><li><a name=ref-32 class=n-a></a><span class=label>32. </span>&nbsp;<span class=citation><a name=d42381e1348 class=n-a></a>Diabetic Retinopathy Clinical Research Network: The course of response to focal/grid photocoagulation for diabetic macular edema. <i>Retina.</i> 2009; <b>29</b>(10): 1436–43. <a target=xrefwindow id=d42381e1356 href="http://www.ncbi.nlm.nih.gov/pubmed/19898182">PubMed Abstract </a> | <a target=xrefwindow id=d42381e1359 href="http://dx.doi.org/10.1097/IAE.0b013e3181bcef6b">Publisher Full Text </a> | <a target=xrefwindow id=d42381e1362 href="http://www.ncbi.nlm.nih.gov/pmc/articles/2787248">Free Full Text </a></span></li><li><a name=ref-33 class=n-a></a><span class=label>33. </span>&nbsp;<span class=citation><a target=_blank title="F1000 recommended" class="research-layout prime-recommended-reference" href="https://f1000.com/prime/725933916"><span class="f1r-icon icon-79_faculty_recommended_badge small red vmiddle"></span></a><a name=d42381e1371 class=n-a></a>Writing Committee for the Diabetic Retinopathy Clinical Research Network, Gross JG, Glassman AR, <i> et al.</i>: Panretinal Photocoagulation vs Intravitreous Ranibizumab for Proliferative Diabetic Retinopathy: A Randomized Clinical Trial. <i>JAMA.</i> 2015; <b>314</b>(20): 2137–46. <a target=xrefwindow id=d42381e1382 href="http://www.ncbi.nlm.nih.gov/pubmed/26565927">PubMed Abstract </a> | <a target=xrefwindow id=d42381e1385 href="http://dx.doi.org/10.1001/jama.2015.15217">Publisher Full Text </a> | <a target=xrefwindow id=d42381e1389 href="http://www.ncbi.nlm.nih.gov/pmc/articles/5567801">Free Full Text </a> | <a target=_blank title="F1000 recommended" href="https://f1000.com/prime/725933916">F1000 Recommendation</a></span></li><li><a name=ref-34 class=n-a></a><span class=label>34. </span>&nbsp;<span class=citation><a target=_blank title="F1000 recommended" class="research-layout prime-recommended-reference" href="https://f1000.com/prime/726299043"><span class="f1r-icon icon-79_faculty_recommended_badge small red vmiddle"></span></a><a name=d42381e1402 class=n-a></a>Chen G, Tzekov R, Li W, <i> et al.</i>: SUBTHRESHOLD MICROPULSE DIODE LASER VERSUS CONVENTIONAL LASER PHOTOCOAGULATION FOR DIABETIC MACULAR EDEMA: A Meta-Analysis of Randomized Controlled Trials. <i>Retina.</i> 2016; <b>36</b>(11): 2059–65. <a target=xrefwindow id=d42381e1413 href="http://www.ncbi.nlm.nih.gov/pubmed/27096529">PubMed Abstract </a> | <a target=xrefwindow id=d42381e1416 href="http://dx.doi.org/10.1097/IAE.0000000000001053">Publisher Full Text </a> | <a target=_blank title="F1000 recommended" href="https://f1000.com/prime/726299043">F1000 Recommendation</a></span></li><li><a name=ref-35 class=n-a></a><span class=label>35. </span>&nbsp;<span class=citation><a target=_blank title="F1000 recommended" class="research-layout prime-recommended-reference" href="https://f1000.com/prime/730127602"><span class="f1r-icon icon-79_faculty_recommended_badge small red vmiddle"></span></a><a name=d42381e1429 class=n-a></a>Cai S, Bressler NM: Aflibercept, bevacizumab or ranibizumab for diabetic macular oedema: recent clinically relevant findings from DRCR.net Protocol T. <i>Curr Opin Ophthalmol.</i> 2017; <b>28</b>(6): 636–43. <a target=xrefwindow id=d42381e1437 href="http://www.ncbi.nlm.nih.gov/pubmed/28837425">PubMed Abstract </a> | <a target=xrefwindow id=d42381e1440 href="http://dx.doi.org/10.1097/ICU.0000000000000424">Publisher Full Text </a> | <a target=_blank title="F1000 recommended" href="https://f1000.com/prime/730127602">F1000 Recommendation</a></span></li><li><a name=ref-36 class=n-a></a><span class=label>36. </span>&nbsp;<span class=citation><a name=d42381e1454 class=n-a></a>Brown DM, Nguyen QD, Marcus DM, <i> et al.</i>: Long-term outcomes of ranibizumab therapy for diabetic macular edema: the 36-month results from two phase III trials: RISE and RIDE. <i>Ophthalmology.</i> 2013; <b>120</b>(10): 2013–22. <a target=xrefwindow id=d42381e1465 href="http://www.ncbi.nlm.nih.gov/pubmed/23706949">PubMed Abstract </a> | <a target=xrefwindow id=d42381e1468 href="http://dx.doi.org/10.1016/j.ophtha.2013.02.034">Publisher Full Text </a></span></li><li><a name=ref-37 class=n-a></a><span class=label>37. </span>&nbsp;<span class=citation><a target=_blank title="F1000 recommended" class="research-layout prime-recommended-reference" href="https://f1000.com/prime/725255751"><span class="f1r-icon icon-79_faculty_recommended_badge small red vmiddle"></span></a><a name=d42381e1477 class=n-a></a>Ip MS, Domalpally A, Sun JK, <i> et al.</i>: Long-term effects of therapy with ranibizumab on diabetic retinopathy severity and baseline risk factors for worsening retinopathy. <i>Ophthalmology.</i> 2015; <b>122</b>(2): 367–74. <a target=xrefwindow id=d42381e1488 href="http://www.ncbi.nlm.nih.gov/pubmed/25439595">PubMed Abstract </a> | <a target=xrefwindow id=d42381e1491 href="http://dx.doi.org/10.1016/j.ophtha.2014.08.048">Publisher Full Text </a> | <a target=_blank title="F1000 recommended" href="https://f1000.com/prime/725255751">F1000 Recommendation</a></span></li><li><a name=ref-38 class=n-a></a><span class=label>38. </span>&nbsp;<span class=citation><a target=_blank title="F1000 recommended" class="research-layout prime-recommended-reference" href="https://f1000.com/prime/718363552"><span class="f1r-icon icon-79_faculty_recommended_badge small red vmiddle"></span></a><a name=d42381e1504 class=n-a></a>Campochiaro PA, Wykoff CC, Shapiro H, <i> et al.</i>: Neutralization of vascular endothelial growth factor slows progression of retinal nonperfusion in patients with diabetic macular edema. <i>Ophthalmology.</i> 2014; <b>121</b>(9): 1783–9. <a target=xrefwindow id=d42381e1515 href="http://www.ncbi.nlm.nih.gov/pubmed/24768239">PubMed Abstract </a> | <a target=xrefwindow id=d42381e1518 href="http://dx.doi.org/10.1016/j.ophtha.2014.03.021">Publisher Full Text </a> | <a target=_blank title="F1000 recommended" href="https://f1000.com/prime/718363552">F1000 Recommendation</a></span></li><li><a name=ref-39 class=n-a></a><span class=label>39. </span>&nbsp;<span class=citation><a target=_blank title="F1000 recommended" class="research-layout prime-recommended-reference" href="https://f1000.com/prime/724709443"><span class="f1r-icon icon-79_faculty_recommended_badge small red vmiddle"></span></a><a name=d42381e1531 class=n-a></a>Diabetic Retinopathy Clinical Research Network, Elman MJ, Aiello LP, <i> et al.</i>: Randomized trial evaluating ranibizumab plus prompt or deferred laser or triamcinolone plus prompt laser for diabetic macular edema. <i>Ophthalmology.</i> 2010; <b>117</b>(6): 1064–1077.e35. <a target=xrefwindow id=d42381e1542 href="http://www.ncbi.nlm.nih.gov/pubmed/20427088">PubMed Abstract </a> | <a target=xrefwindow id=d42381e1545 href="http://dx.doi.org/10.1016/j.ophtha.2010.02.031">Publisher Full Text </a> | <a target=xrefwindow id=d42381e1549 href="http://www.ncbi.nlm.nih.gov/pmc/articles/2937272">Free Full Text </a> | <a target=_blank title="F1000 recommended" href="https://f1000.com/prime/724709443">F1000 Recommendation</a></span></li><li><a name=ref-40 class=n-a></a><span class=label>40. </span>&nbsp;<span class=citation><a target=_blank title="F1000 recommended" class="research-layout prime-recommended-reference" href="https://f1000.com/prime/727277409"><span class="f1r-icon icon-79_faculty_recommended_badge small red vmiddle"></span></a><a name=d42381e1562 class=n-a></a>Bressler SB, Qin H, Melia M, <i> et al.</i>: Exploratory analysis of the effect of intravitreal ranibizumab or triamcinolone on worsening of diabetic retinopathy in a randomized clinical trial. <i>JAMA Ophthalmol.</i> 2013; <b>131</b>(8): 1033–40. <a target=xrefwindow id=d42381e1573 href="http://www.ncbi.nlm.nih.gov/pubmed/23807371">PubMed Abstract </a> | <a target=xrefwindow id=d42381e1576 href="http://dx.doi.org/10.1001/jamaophthalmol.2013.4154">Publisher Full Text </a> | <a target=xrefwindow id=d42381e1580 href="http://www.ncbi.nlm.nih.gov/pmc/articles/4162127">Free Full Text </a> | <a target=_blank title="F1000 recommended" href="https://f1000.com/prime/727277409">F1000 Recommendation</a></span></li><li><a name=ref-41 class=n-a></a><span class=label>41. </span>&nbsp;<span class=citation><a target=_blank title="F1000 recommended" class="research-layout prime-recommended-reference" href="https://f1000.com/prime/727273826"><span class="f1r-icon icon-79_faculty_recommended_badge small red vmiddle"></span></a><a name=d42381e1593 class=n-a></a>Bressler SB, Beaulieu WT, Glassman AR, <i> et al.</i>: Factors Associated with Worsening Proliferative Diabetic Retinopathy in Eyes Treated with Panretinal Photocoagulation or Ranibizumab. <i>Ophthalmology.</i> 2017; <b>124</b>(4): 431–9. <a target=xrefwindow id=d42381e1604 href="http://www.ncbi.nlm.nih.gov/pubmed/28161147">PubMed Abstract </a> | <a target=xrefwindow id=d42381e1607 href="http://dx.doi.org/10.1016/j.ophtha.2016.12.005">Publisher Full Text </a> | <a target=_blank title="F1000 recommended" href="https://f1000.com/prime/727273826">F1000 Recommendation</a></span></li><li><a name=ref-42 class=n-a></a><span class=label>42. </span>&nbsp;<span class=citation><a target=_blank title="F1000 recommended" class="research-layout prime-recommended-reference" href="https://f1000.com/prime/725663868"><span class="f1r-icon icon-79_faculty_recommended_badge small red vmiddle"></span></a><a name=d42381e1621 class=n-a></a>Brown DM, Schmidt-Erfurth U, Do DV, <i> et al.</i>: Intravitreal Aflibercept for Diabetic Macular Edema: 100-Week Results From the VISTA and VIVID Studies. <i>Ophthalmology.</i> 2015; <b>122</b>(10): 2044–52. <a target=xrefwindow id=d42381e1632 href="http://www.ncbi.nlm.nih.gov/pubmed/26198808">PubMed Abstract </a> | <a target=xrefwindow id=d42381e1635 href="http://dx.doi.org/10.1016/j.ophtha.2015.06.017">Publisher Full Text </a> | <a target=_blank title="F1000 recommended" href="https://f1000.com/prime/725663868">F1000 Recommendation</a></span></li><li><a name=ref-43 class=n-a></a><span class=label>43. </span>&nbsp;<span class=citation><a target=_blank title="F1000 recommended" class="research-layout prime-recommended-reference" href="https://f1000.com/prime/727557467"><span class="f1r-icon icon-79_faculty_recommended_badge small red vmiddle"></span></a><a name=d42381e1648 class=n-a></a>Bressler SB, Liu D, Glassman AR, <i> et al.</i>: Change in Diabetic Retinopathy Through 2 Years: Secondary Analysis of a Randomized Clinical Trial Comparing Aflibercept, Bevacizumab, and Ranibizumab. <i>JAMA Ophthalmol.</i> 2017; <b>135</b>(6): 558–68. <a target=xrefwindow id=d42381e1659 href="http://www.ncbi.nlm.nih.gov/pubmed/28448655">PubMed Abstract </a> | <a target=xrefwindow id=d42381e1662 href="http://dx.doi.org/10.1001/jamaophthalmol.2017.0821">Publisher Full Text </a> | <a target=xrefwindow id=d42381e1666 href="http://www.ncbi.nlm.nih.gov/pmc/articles/5540030">Free Full Text </a> | <a target=_blank title="F1000 recommended" href="https://f1000.com/prime/727557467">F1000 Recommendation</a></span></li><li><a name=ref-44 class=n-a></a><span class=label>44. </span>&nbsp;<span class=citation><a target=_blank title="F1000 recommended" class="research-layout prime-recommended-reference" href="https://f1000.com/prime/9575959"><span class="f1r-icon icon-79_faculty_recommended_badge small red vmiddle"></span></a><a name=d42381e1679 class=n-a></a>Michaelides M, Kaines A, Hamilton RD, <i> et al.</i>: A prospective randomized trial of intravitreal bevacizumab or laser therapy in the management of diabetic macular edema (BOLT study) 12-month data: report 2. <i>Ophthalmology.</i> 2010; <b>117</b>(6): 1078–1086.e2. <a target=xrefwindow id=d42381e1690 href="http://www.ncbi.nlm.nih.gov/pubmed/20416952">PubMed Abstract </a> | <a target=xrefwindow id=d42381e1693 href="http://dx.doi.org/10.1016/j.ophtha.2010.03.045">Publisher Full Text </a> | <a target=_blank title="F1000 recommended" href="https://f1000.com/prime/9575959">F1000 Recommendation</a></span></li><li><a name=ref-45 class=n-a></a><span class=label>45. </span>&nbsp;<span class=citation><a target=_blank title="F1000 recommended" class="research-layout prime-recommended-reference" href="https://f1000.com/prime/726191373"><span class="f1r-icon icon-79_faculty_recommended_badge small red vmiddle"></span></a><a name=d42381e1706 class=n-a></a>Wells JA, Glassman AR, Ayala AR, <i> et al.</i>: Aflibercept, Bevacizumab, or Ranibizumab for Diabetic Macular Edema: Two-Year Results from a Comparative Effectiveness Randomized Clinical Trial. <i>Ophthalmology.</i> 2016; <b>123</b>(6): 1351–9. <a target=xrefwindow id=d42381e1717 href="http://www.ncbi.nlm.nih.gov/pubmed/26935357">PubMed Abstract </a> | <a target=xrefwindow id=d42381e1720 href="http://dx.doi.org/10.1016/j.ophtha.2016.02.022">Publisher Full Text </a> | <a target=xrefwindow id=d42381e1724 href="http://www.ncbi.nlm.nih.gov/pmc/articles/4877252">Free Full Text </a> | <a target=_blank title="F1000 recommended" href="https://f1000.com/prime/726191373">F1000 Recommendation</a></span></li><li><a name=ref-46 class=n-a></a><span class=label>46. </span>&nbsp;<span class=citation><a target=_blank title="F1000 recommended" class="research-layout prime-recommended-reference" href="https://f1000.com/prime/731842597"><span class="f1r-icon icon-79_faculty_recommended_badge small red vmiddle"></span></a><a name=d42381e1737 class=n-a></a>Shah AR, Yonekawa Y, Todorich B, <i> et al.</i>: Prediction of Anti-VEGF Response in Diabetic Macular Edema After 1 Injection. <i>J Vitreoretin Dis.</i> 2017; <b>1</b>(3): 169–74. <a target=xrefwindow id=d42381e1748 href="http://www.ncbi.nlm.nih.gov/pubmed/29104958">PubMed Abstract </a> | <a target=xrefwindow id=d42381e1751 href="http://dx.doi.org/10.1177/2474126416682569">Publisher Full Text </a> | <a target=xrefwindow id=d42381e1755 href="http://www.ncbi.nlm.nih.gov/pmc/articles/5668872">Free Full Text </a> | <a target=_blank title="F1000 recommended" href="https://f1000.com/prime/731842597">F1000 Recommendation</a></span></li><li><a name=ref-47 class=n-a></a><span class=label>47. </span>&nbsp;<span class=citation><a target=_blank title="F1000 recommended" class="research-layout prime-recommended-reference" href="https://f1000.com/prime/726728632"><span class="f1r-icon icon-79_faculty_recommended_badge small red vmiddle"></span></a><a name=d42381e1768 class=n-a></a>Lee J, Moon BG, Cho AR, <i> et al.</i>: Optical Coherence Tomography Angiography of DME and Its Association with Anti-VEGF Treatment Response. <i>Ophthalmology.</i> 2016; <b>123</b>(11): 2368–75. <a target=xrefwindow id=d42381e1779 href="http://www.ncbi.nlm.nih.gov/pubmed/27613201">PubMed Abstract </a> | <a target=xrefwindow id=d42381e1782 href="http://dx.doi.org/10.1016/j.ophtha.2016.07.010">Publisher Full Text </a> | <a target=_blank title="F1000 recommended" href="https://f1000.com/prime/726728632">F1000 Recommendation</a></span></li><li><a name=ref-48 class=n-a></a><span class=label>48. </span>&nbsp;<span class=citation><a name=d42381e1796 class=n-a></a>Simó R, Hernández C: Intravitreous anti-VEGF for diabetic retinopathy: hopes and fears for a new therapeutic strategy. <i>Diabetologia.</i> 2008; <b>51</b>(9): 1574–80. <a target=xrefwindow id=d42381e1804 href="http://www.ncbi.nlm.nih.gov/pubmed/18404258">PubMed Abstract </a> | <a target=xrefwindow id=d42381e1807 href="http://dx.doi.org/10.1007/s00125-008-0989-9">Publisher Full Text </a></span></li><li><a name=ref-49 class=n-a></a><span class=label>49. </span>&nbsp;<span class=citation><a target=_blank title="F1000 recommended" class="research-layout prime-recommended-reference" href="https://f1000.com/prime/718438658"><span class="f1r-icon icon-79_faculty_recommended_badge small red vmiddle"></span></a><a name=d42381e1816 class=n-a></a>Boyer DS, Yoon YH, Belfort R Jr, <i> et al.</i>: Three-year, randomized, sham-controlled trial of dexamethasone intravitreal implant in patients with diabetic macular edema. <i>Ophthalmology.</i> 2014; <b>121</b>(10): 1904–14. <a target=xrefwindow id=d42381e1827 href="http://www.ncbi.nlm.nih.gov/pubmed/24907062">PubMed Abstract </a> | <a target=xrefwindow id=d42381e1830 href="http://dx.doi.org/10.1016/j.ophtha.2014.04.024">Publisher Full Text </a> | <a target=_blank title="F1000 recommended" href="https://f1000.com/prime/718438658">F1000 Recommendation</a></span></li><li><a name=ref-50 class=n-a></a><span class=label>50. </span>&nbsp;<span class=citation><a target=_blank title="F1000 recommended" class="research-layout prime-recommended-reference" href="https://f1000.com/prime/725947844"><span class="f1r-icon icon-79_faculty_recommended_badge small red vmiddle"></span></a><a name=d42381e1843 class=n-a></a>Danis RP, Sadda S, Li XY, <i> et al.</i>: Anatomical effects of dexamethasone intravitreal implant in diabetic macular oedema: a pooled analysis of 3-year phase III trials. <i>Br J Ophthalmol.</i> 2016; <b>100</b>(6): 796–801. <a target=xrefwindow id=d42381e1854 href="http://www.ncbi.nlm.nih.gov/pubmed/26581718">PubMed Abstract </a> | <a target=xrefwindow id=d42381e1857 href="http://dx.doi.org/10.1136/bjophthalmol-2015-306823">Publisher Full Text </a> | <a target=xrefwindow id=d42381e1861 href="http://www.ncbi.nlm.nih.gov/pmc/articles/4893085">Free Full Text </a> | <a target=_blank title="F1000 recommended" href="https://f1000.com/prime/725947844">F1000 Recommendation</a></span></li><li><a name=ref-51 class=n-a></a><span class=label>51. </span>&nbsp;<span class=citation><a target=_blank title="F1000 recommended" class="research-layout prime-recommended-reference" href="https://f1000.com/prime/717950703"><span class="f1r-icon icon-79_faculty_recommended_badge small red vmiddle"></span></a><a name=d42381e1874 class=n-a></a>Campochiaro PA, Brown DM, Pearson A, <i> et al.</i>: Sustained delivery fluocinolone acetonide vitreous inserts provide benefit for at least 3 years in patients with diabetic macular edema. <i>Ophthalmology.</i> 2012; <b>119</b>(10): 2125–32. <a target=xrefwindow id=d42381e1885 href="http://www.ncbi.nlm.nih.gov/pubmed/22727177">PubMed Abstract </a> | <a target=xrefwindow id=d42381e1888 href="http://dx.doi.org/10.1016/j.ophtha.2012.04.030">Publisher Full Text </a> | <a target=_blank title="F1000 recommended" href="https://f1000.com/prime/717950703">F1000 Recommendation</a></span></li><li><a name=ref-52 class=n-a></a><span class=label>52. </span>&nbsp;<span class=citation><a target=_blank title="F1000 recommended" class="research-layout prime-recommended-reference" href="https://f1000.com/prime/726348482"><span class="f1r-icon icon-79_faculty_recommended_badge small red vmiddle"></span></a><a name=d42381e1901 class=n-a></a>Hernández C, Dal Monte M, Simó R, <i> et al.</i>: Neuroprotection as a Therapeutic Target for Diabetic Retinopathy. <i>J Diabetes Res.</i> 2016; <b>2016</b>: 9508541. <a target=xrefwindow id=d42381e1912 href="http://www.ncbi.nlm.nih.gov/pubmed/27123463">PubMed Abstract </a> | <a target=xrefwindow id=d42381e1915 href="http://dx.doi.org/10.1155/2016/9508541">Publisher Full Text </a> | <a target=xrefwindow id=d42381e1919 href="http://www.ncbi.nlm.nih.gov/pmc/articles/4830713">Free Full Text </a> | <a target=_blank title="F1000 recommended" href="https://f1000.com/prime/726348482">F1000 Recommendation</a></span></li></ul></div></div></div> </div> <div id=article-comments class="article-comments padding-bottom-20"> <div class=current-article-comment-section> <h2 class=main-title name=add-new-comment id=add-new-comment> <span class="research-layout f1r-article-mobile-inline valign-middle"> <span class="f1r-icon icon-104_comments size30"></span> </span> <span class=f1r-article-desk-inline>Comments on this article</span> <span class=f1r-article-mobile-inline>Comments (0)</span> <span class="f1r-article-mobile-inline float-right"> <span class="f1r-icon icon-14_more_small"></span> <span class="f1r-icon icon-10_less_small"></span> </span> </h2> </div> <div class="f1r-article-desk-inline referee-report-info-box referee-report-version-box"> Version 1 </div> <div class="f1r-article-mobile research-layout mobile-version-info padding-top-30"> <span class=mversion>VERSION 1</span> <span class=details>PUBLISHED 29 Nov 2017</span> <span class="article-pubinfo-mobile versions-section"> </span> </div> <div class="f1r-article-mobile research-layout margin-top-20 is-centered"> <a href="/login?originalPath=/articles/6-2063&scrollTo=add-new-comment" class=register-report-comment-button data-test-id=add-comment_mob> <button class="primary orange extra-padding comment-on-this-report">ADD YOUR COMMENT</button> </a> </div> <a href="/login?originalPath=/articles/6-2063&scrollTo=add-new-comment" class="f1r-article-desk register-report-comment-button" data-test-id=add-comment> <span class=contracted></span>Comment </a> </div> <div class="f1r-article-mobile margin-bottom-30"> <div class=contracted-details> <a href="#" class="contracted-details-label author-affiliations"><span class=contracted></span>Author details</a> <a href="#" class=section-title>Author details</a> <span class="f1r-icon icon-14_more_small section-control"></span> <span class="f1r-icon icon-10_less_small section-control"></span> <div class="expanded-details affiliations is-hidden"> Byers Eye Institute, Stanford University School of Medicine, 2452 Watson Court, Palo Alto, CA, 94303, USA<br/> <p> <div class=margin-bottom> Matthew Powers <br/> <span>Roles: </span> Conceptualization, Data Curation, Investigation, Methodology, Writing – Original Draft Preparation, Writing – Review & Editing </div> <div class=margin-bottom> Margaret Greven <br/> <span>Roles: </span> Conceptualization, Methodology, Resources, Writing – Original Draft Preparation </div> <div class=margin-bottom> Robert Kleinman <br/> <span>Roles: </span> Conceptualization, Investigation </div> <div class=margin-bottom> Quan Dong Nguyen <br/> <span>Roles: </span> Conceptualization, Supervision, Writing – Original Draft Preparation, Writing – Review & Editing </div> <div class=margin-bottom> Diana Do <br/> <span>Roles: </span> Conceptualization, Investigation, Methodology, Resources, Supervision, Writing – Original Draft Preparation, Writing – Review & Editing </div> </p> </div> </div> <div class=contracted-details> <a href="#" class=section-title>Article Versions (1)</a> <span class="f1r-icon icon-14_more_small section-control"></span> <span class="f1r-icon icon-10_less_small section-control"></span> <div class="expanded-details grant-information article-page is-hidden"> <div> <a href="https://f1000research.com/articles/6-2063/v1" title="Open version 1 of this article." class="" gahelper=1>version 1</a> <span class="article-pubinfo-mobile versions-section"> </span> </div> <div> Published: 29 Nov 2017, 6:2063 </div> <div class=""><a href="https://doi.org/10.12688/f1000research.12662.1">https://doi.org/10.12688/f1000research.12662.1</a></div> </div> </div> <div class=contracted-details> <a href="#" class=section-title> <span class="f1r-icon icon-100_open_access"></span> Copyright </a> <span class="f1r-icon icon-14_more_small section-control"></span> <span class="f1r-icon icon-10_less_small section-control"></span> <div class="expanded-details grant-information article-page is-hidden"> © 2017 Powers M <em>et al</em>. This is an open access article distributed under the terms of the <a href="http://creativecommons.org/licenses/by/4.0/" target=_blank data-test-id=box-licence-link>Creative Commons Attribution License</a>, which permits unrestricted use, distribution, and reproduction in any medium, provided the original work is properly cited. </div> </div> <div class="padding-top-30 research-layout"> <div class=article-toolbox-wrapper-mobile> <div class=article-tools-icon-mobile data-section=download> <span class="f1r-icon icon-76_download_file white"></span> </div> <div class="article-tools-icon-mobile mobile-metrics article-metrics-wrapper metrics-icon-wrapper" data-section=metrics data-version-id=13709 data-id=12662 data-downloads="" data-views="" data-scholar="10.12688/f1000research.12662.1" data-recommended="" data-f1r-ga-helper="Article Page Metrics (Mobile)"> <span class="f1r-icon icon-89_metrics white"></span> </div> <div class=article-tools-divider-mobile></div> <div class=article-tools-icon-mobile data-section=cite> <span class="f1r-icon icon-82_quote white"></span> </div> <div class="article-tools-icon-mobile " data-section=track> <span class="f1r-icon icon-90_track white"></span> </div> <div class=article-tools-divider-mobile></div> <div class=article-tools-icon-mobile data-section=share> <span class="f1r-icon icon-34_share white"></span> </div> <span class=article-toolbox-stretch></span> </div> <div class=article-toolbox-content-mobile> <div class="toolbox-section download"> <div class=toolbox-section-heading>Download</div> <div class=toolbox-section-content> <a href="https://f1000research.com/articles/6-2063/v1/pdf?article_uuid=5da9cb2b-47ad-4171-83f8-33d1e3155e33" title="Download PDF" class="no-decoration pdf-download-helper"> <span class="f1r-icon icon-102_download_pdf toolbox-section-icon"></span> </a> <div class=toolbox-section-option-divider>&nbsp;</div> <a id=mobile-download-xml class=no-decoration href="#" title="Download XML"> <span class="f1r-icon icon-103_download_xml toolbox-section-icon"></span> </a> </div> <div class=toolbox-section-divider></div> <div class=toolbox-section-heading>Export To</div> <div class=toolbox-section-content> <button class="primary no-fill orange-text-and-border mobile-export" data-etype=WORKSPACE>Sciwheel</button> <button class="primary no-fill orange-text-and-border mobile-export" data-etype=BIBTEX>Bibtex</button> <button class="primary no-fill orange-text-and-border mobile-export" data-etype=ENDNOTE>EndNote</button> <button class="primary no-fill orange-text-and-border mobile-export" data-etype=PROCITE>ProCite</button> <button class="primary no-fill orange-text-and-border mobile-export" data-etype=REF_MANAGER>Ref. Manager (RIS)</button> <button class="primary no-fill orange-text-and-border mobile-export" data-etype=SENTE>Sente</button> </div> </div> <div class="toolbox-section metrics"> <div class="toolbox-section-heading no-top-border">metrics</div> <div class="toolbox-section-divider toolbox-section-divider--no-height"></div> <div class=article-metrics-pageinfo> <div class=c-article-metrics-table> <table class=c-article-metrics-table__table> <thead> <tr> <th></th> <th><span class=c-article-metrics-table__heading>Views</span></th> <th><span class=c-article-metrics-table__heading>Downloads</span></th> </tr> </thead> <tbody> <tr> <th class=c-article-metrics-table__row-heading><span class="c-article-metrics-table__platform u-platform--" data-test-id=metrics_platform_name_mob>F1000Research</span></th> <td class="c-article-metrics-table__value js-article-views-count" data-test-id=metrics_platform_views_mob>-</td> <td class="c-article-metrics-table__value js-article-downloads-count" data-test-id=metrics_platform_downloads_mob>-</td> </tr> <tr> <th class=c-article-metrics-table__row-heading> <span class="u-ib u-middle c-article-metrics-table__pmc" data-test-id=metrics_pmc_name_mob>PubMed Central</span> <div class="c-block-tip c-block-tip--centered c-article-metrics-table__tooltip c-block-tip--md-padding c-block-tip--small-arrow u-ib u-middle"> <button type=button class="u-black--medium u-black--high@hover u-ib u-middle c-button--icon c-button--text c-block-tip__toggle"><i class="material-icons c-button--icon__icon">info_outline</i></button> <div class=c-block-tip__content>Data from PMC are received and updated monthly.</div> </div> </th> <td class="c-article-metrics-table__value js-pmc-views-count" data-test-id=metrics_pmc_views_mob>-</td> <td class="c-article-metrics-table__value js-pmc-downloads-count" data-test-id=metrics_pmc_downloads_mob>-</td> </tr> </tbody> </table> </div> </div> <span class=metrics-citations-container> <div class=toolbox-section-divider></div> <div class="toolbox-section-heading u-mb--1">Citations</div> <div> <div class=toolbox-section-colsplit> <div class=citations-scopus-logo> <a href="" target=_blank class="is-hidden metrics-citation-icon" title="View full citation details at www.scopus.com"><i class="material-icons scopus-icon">open_in_new</i></a> </div> <div class="toolbox-section-count scopus"> <a href='' class='scopus-citation-link is-hidden' target=_blank title='View full citation details at www.scopus.com'>0</a> </div> </div> <div class=toolbox-section-colsplit> <div class="citations-pubmed-logo f1000research"> <a href="" target=_blank class="is-hidden metrics-citation-icon f1000research" title="View full citation details"><i class="material-icons scopus-icon">open_in_new</i></a> </div> <div class="toolbox-section-count pubmed"> <a href='' class='pubmed-citation-link is-hidden' target=_blank title='View full citation details'>0</a> </div> </div> <div class=toolbox-section-divider></div> <div class=toolbox-section-content> <div class="citations-scholar-logo f1000research"> <a href="" target=_blank class="is-hidden metrics-citation-icon google-scholar f1000research" title="View full citation details" data-scholar="10.12688/f1000research.12662.1"><i class="material-icons scopus-icon">open_in_new</i></a> </div> </div> </div> </span> <span class=metrics-details-container> <div class=toolbox-section-divider></div> <div class="toolbox-section-content altmetric-section"> <div class=altmetrics-image></div> <div class=altmetrics-more-link> <a href="" target=_blank class=f1r-standard-link>SEE MORE DETAILS</a> </div> <div class=altmetric-mobile-column-counts></div> <div class=altmetric-mobile-column-readers></div> <div class=toolbox-section-divider></div> </div> </span> </div> <div class="toolbox-section cite"> <div class="toolbox-section-heading no-top-border">CITE</div> <div class=toolbox-section-divider></div> <div class=toolbox-section-heading>how to cite this article</div> <div id=citation-copy-mobile class="toolbox-section-content text-content heading9 small" data-test-id=mob_copy-citation_text> Powers M, Greven M, Kleinman R <em>et al.</em> Recent advances in the management and understanding of diabetic retinopathy [version 1; peer review: 2 approved] <i>F1000Research</i> 2017, <b>6</b>(F1000 Faculty Rev):2063 (<a href="https://doi.org/10.12688/f1000research.12662.1" target=_blank>https://doi.org/10.12688/f1000research.12662.1</a>) </div> <div class=toolbox-section-divider></div> <div class="toolbox-section-content text-content heading9 small"> NOTE: <em>it is important to ensure the information in <b>square brackets after the title</b> is included in all citations of this article.</em> </div> <div class=toolbox-section-content> <button class="primary orange extra-padding copy-cite-article-mobile js-clipboard" data-clipboard-target="#citation-copy-mobile" title="Copy the current citation details." data-test-id=mob_copy-citation_button-mob>COPY CITATION DETAILS</button> </div> </div> <div class="toolbox-section track"> <div class="toolbox-section-heading no-top-border">track</div> <div class=toolbox-section-divider></div> <div class=toolbox-section-heading>receive updates on this article</div> <div class="toolbox-section-content padding-left-20 padding-right-20 heading9 small"> Track an article to receive email alerts on any updates to this article. </div> <div class=toolbox-section-content> <a data-article-id=12662 id=mobile-track-article-signin-12662 title="Receive updates on new activity such as publication of new versions, peer reviews or author responses." href="/login?originalPath=/trackArticle/12662?target=/articles/6-2063"> <button class="primary orange extra-padding"> TRACK THIS ARTICLE </button> </a> </div> </div> <div class="toolbox-section share"> <div class="toolbox-section-heading no-top-border">Share</div> <div class=toolbox-section-divider></div> <div class=toolbox-section-content> <a target=_blank class="f1r-shares-icon-square f1r-shares-email" title="Email this article"></a> <a target=_blank class="f1r-shares-icon-square f1r-shares-twitter" title="Share on Twitter"></a> <a target=_blank class="f1r-shares-icon-square f1r-shares-facebook" title="Share on Facebook"></a> <a target=_blank class="f1r-shares-icon-square f1r-shares-linkedin" title="Share on LinkedIn"></a> <a target=_blank class="f1r-shares-icon-square f1r-shares-reddit" title="Share on Reddit"></a> <a target=_blank class="f1r-shares-icon-square f1r-shares-mendelay" title="Share on Mendeley"></a> <div class="email-article-wrapper email-article-version-container"> <div class=toolbox-section-divider></div> <script src='https://www.recaptcha.net/recaptcha/api.js'></script> <form class="recommend-version-form-mobile research-layout"> <p>All fields are required.</p> <input name=versionId type=hidden value=13709 /> <input name=articleId type=hidden value=12662 /> <input name=senderName class="form-input-field reg-form" value="" type=text placeholder="Your name"/> <input name=senderEmail class="form-input-field reg-form margin-top" value="" type=text placeholder="Your email address"/> <textarea name=recipientEmails class="form-textarea-field ninetynine-percent-wide margin-top no-resize" placeholder="Recipient email address(es) (comma delimited)"></textarea> <input class="form-input-field reg-form margin-top" name=subject type=text value="Interesting article on F1000Research" placeholder=Subject /> <textarea name=message class="form-textarea-field reg-form margin-top no-resize">I thought this article from F1000Research (https://f1000research.com) would be of interest to you.</textarea> <div class="g-recaptcha margin-top" data-sitekey=6LcHqxoUAAAAANP3_0TzpGG6qFvl4DhbUcuRzw7W></div> <input value="" name=captcha type=hidden /> <p>A full article citation will be automatically included.</p> <p><img class="ticker-email-article-details hidden" src="/img/ticker.gif" alt=loading /></p> <button class="secondary orange margin-bottom" data-test-id=version_share_email_send>SEND EMAIL</button> <div class="orange-message margin-bottom is-hidden" data-test-id=version_share_email_message></div> </form> </div> </div> </div> </div> </div> <a name=article-reports></a> <div id=article-reports class="u-mt--3 reports-comments no-divider"> <div class="current-referee-status current-referee-status--faculty "> <h2 class=main-title id=current-referee-status> <span class="research-layout f1r-article-mobile-inline valign-middle"> <span class="f1r-icon icon-85_peer_review size30"></span> </span> Open Peer Review <span class="f1r-article-mobile-inline float-right"> <span class="f1r-icon icon-14_more_small"></span> <span class="f1r-icon icon-10_less_small"></span> </span> </h2> <a name=current-referee-status></a> <div class=current-referee-status__content name=add-new-report-comment id=add-new-report-comment> Current Reviewer Status: <span class="research-layout f1r-article-desk-inline"> <span class="f1r-icon icon-86_approved status-green smaller" title=Approved></span> </span> <span class="research-layout f1r-article-mobile float-right"> <span class="f1r-icon icon-86_approved status-green smaller" title=Approved></span> </span> <span class="research-layout f1r-article-desk-inline"> <span class="f1r-icon icon-86_approved status-green smaller" title=Approved></span> </span> <span class="research-layout f1r-article-mobile float-right"> <span class="f1r-icon icon-86_approved status-green smaller" title=Approved></span> </span> <span class="research-layout f1r-article-mobile"> <div class=mobile-ref-status-help> Key to Reviewer Statuses <span class=referee-status-pointer></span> <span class="view-control float-right">VIEW</span> <span class="view-control float-right is-hidden">HIDE</span> <div class=mobile-ref-status-help-content> <div class="cf margin-top"> <span class="f1r-icon icon-86_approved status-green smaller float-left margin-bottom-40 margin-right" title=Approved></span> <span class=title>Approved</span>The paper is scientifically sound in its current form and only minor, if any, improvements are suggested </div> <div class="cf margin-top"> <span class="f1r-icon icon-87_approved_reservations status-green smaller float-left margin-bottom-40 margin-right" title="Approved with Reservations"></span> <span class=title>Approved with reservations</span> A number of small changes, sometimes more significant revisions are required to address specific details and improve the papers academic merit. </div> <div class="cf margin-top"> <span class="f1r-icon icon-88_not_approved status-red small float-left margin-bottom-30 margin-right" title="Not Approved"></span> <span class=title>Not approved</span>Fundamental flaws in the paper seriously undermine the findings and conclusions </div> </div> </div> </span> <div class=editorial-note> <h5 class=editorial-note__title>Editorial Note on the Review Process</h5> <p class=editorial-note__text><a href="/browse/faculty-reviews">Faculty Reviews</a> are review articles written by the prestigious Members of <a href="https://facultyopinions.com/prime/home">Faculty Opinions</a>. The articles are commissioned and peer reviewed before publication to ensure that the final, published version is comprehensive and accessible. The reviewers who approved the final version are listed with their names and affiliations.</p> </div> <div class=approved-referee> <h4 class=approved-referee__title>Reviewers who approved this article</h4> <ol class=approved-referee__list> <li class="approved-referee__list-item "> <span class=approved-referee__co-referee> <strong>Cristina Hern&aacute;ndez</strong>, Diabetes and Metabolism Research Unit, Vall d'Hebron Research Institute, Universitat Autònoma de Barcelona, Spain </span> <span class=approved-referee__competing-list> <strong>Competing interests:</strong> No competing interests were declared. (for version 1) <br> </span> </li> <li class="approved-referee__list-item margin-top-20"> <span class=approved-referee__co-referee> <strong>Harry W Flynn</strong>, Department of Ophthalmology, Bascom Palmer Eye Institute, University of Miami Miller School of Medicine, USA </span> <span class=approved-referee__competing-list> <strong>Competing interests:</strong> No competing interests were declared. (for version 1) <br> </span> <span class=approved-referee__co-referee> <strong>Nidhi Relhan</strong>, Department of Ophthalmology, Bascom Palmer Eye Institute, University of Miami miller School of Medicine, USA </span> <span class=approved-referee__competing-list> <strong>Competing interests:</strong> No competing interests were declared. (for version 1) <br> </span> </li> </ol> </div> </div> </div> </div> <div class="f1r-article-mobile research-layout"> <div class="mobile-sections-divider before-comments"></div> </div> <div id=article-comments class="article-comments padding-bottom-20"> <div class=current-article-comment-section> <h2 class=main-title name=add-new-comment id=add-new-comment> <span class="research-layout f1r-article-mobile-inline valign-middle"> <span class="f1r-icon icon-104_comments size30"></span> </span> <span class=f1r-article-desk-inline>Comments on this article</span> <span class=f1r-article-mobile-inline>Comments (0)</span> <span class="f1r-article-mobile-inline float-right"> <span class="f1r-icon icon-14_more_small"></span> <span class="f1r-icon icon-10_less_small"></span> </span> </h2> </div> <div class="f1r-article-desk-inline referee-report-info-box referee-report-version-box"> Version 1 </div> <div class="f1r-article-mobile research-layout mobile-version-info padding-top-30"> <span class=mversion>VERSION 1</span> <span class=details>PUBLISHED 29 Nov 2017</span> <span class="article-pubinfo-mobile versions-section"> </span> </div> <div class="f1r-article-mobile research-layout margin-top-20 is-centered"> <a href="/login?originalPath=/articles/6-2063&scrollTo=add-new-comment" class=register-report-comment-button data-test-id=add-comment_mob> <button class="primary orange extra-padding comment-on-this-report">ADD YOUR COMMENT</button> </a> </div> <a href="/login?originalPath=/articles/6-2063&scrollTo=add-new-comment" class="f1r-article-desk register-report-comment-button" data-test-id=add-comment> <span class=contracted></span>Comment </a> </div> </div> </div> <div id=article_main-column class="p-article__sidebar o-layout__item u-1/3 not-expanded js-article-sidebar"> <div class="o-tab p-article__column-toggle-container"> <button class="c-tab c-tab--left js-column-toggle p-article__column-toggle not-expanded " type=button data-target-main=article_main-column data-target-secondary=article_secondary-column><i class="c-tab__icon material-icons u-hide@expanded">keyboard_arrow_left</i><i class="c-tab__icon material-icons u-show@expanded">keyboard_arrow_right</i></button> </div> <div class=p-article__sidebar-content> <div class="p-article__sidebar-scroller js-article-sidebar-scroller"> <section class="p-article__sidebar-view js-article-sidebar-view js-article-sidebar-main u-pt u-pb--8" data-view=peer-review> <div class="o-layout o-layout--flush"> <div class="o-layout__item u-pl"> <h3 class="u-mt--0 u-mb--2 t-h3 u-weight--md u-pl" data-test-id=article_sidebar_heading>Open Peer Review</h3> </div> <div class=o-layout__item> <section class=""> <div class="p-article__sidebar-highlight u-mb--2 u-pr--1"> <div class="o-actions o-actions--middle"> <div class=o-actions__primary> <h4 class="u-mt--0 u-mb--0 u-ib u-middle t-h4 u-weight--md u-mr--1/2">Reviewer Status</h4> <div class="c-referee-status__icons u-ib u-middle"> <i class="c-icn--f1r-icon c-icn--approved " title=Approved #data-refInfo=28314-28275></i> <i class="c-icn--f1r-icon c-icn--approved " title=Approved #data-refInfo=28320-28276></i> </div> </div> <div class="o-actions__secondary _mdl-layout"> <div class="c-block-tip p-article__sidebar-tooltip c-block-tip--below c-block-tip--small-arrow c-block-tip--sm-padding"> <button type=button class="c-button c-button--icon c-button--text c-block-tip__toggle"><i class="material-icons c-button--icon__icon">info_outline</i></button> <div class=c-block-tip__content> <p class="t-body u-mt--0 u-mb--0"><em class=u-weight--md>Alongside their report, reviewers assign a status to the article:</em></p> <dl class=c-definitions> <dt class="c-definitions__term u-upper t-control u-weight--md u-black--high"><span class="u-ib u-middle"> <i class="c-icn--f1r-icon c-icn--approved " title=Approved #data-refInfo=""></i> </span> <span class="u-middle u-ib u-ml--1/2">Approved</span></dt> <dd class="c-definitions__description t-caption">The paper is scientifically sound in its current form and only minor, if any, improvements are suggested</dd> <dt class="c-definitions__term u-upper t-control u-weight--md u-black--high"><span class="u-ib u-middle"> <i class="c-icn--f1r-icon c-icn--reservations" title="Approved with Reservations" #data-refInfo=""></i> </span> <span class="u-middle u-ib u-ml--1/2">Approved with reservations</span></dt> <dd class="c-definitions__description t-caption"> A number of small changes, sometimes more significant revisions are required to address specific details and improve the papers academic merit. </dd> <dt class="c-definitions__term u-upper t-control u-weight--md u-black--high"><span class="u-ib u-middle"> <i class="c-icn--f1r-icon c-icn--not-approved " title="Not Approved" #data-refInfo=""></i> </span> <span class="u-middle u-ib u-ml--1/2">Not approved</span></dt> <dd class="c-definitions__description t-caption">Fundamental flaws in the paper seriously undermine the findings and conclusions</dd> </dl> </div> </div> </div> </div> </div> <div class="o-layout__item u-mb--1"><h4 class="u-mt--0 u-mb--0 u-ib u-middle t-h4 u-weight--md">Reviewer Reports</h4></div> <table class="c-report-timeline u-mb--2"> <thead class=c-report-timeline__headings> <tr> <th></th> <th class="u-pb--1/2" colspan=2><em class="t-body u-weight--rg">Invited Reviewers</em></th> </tr> <tr class=c-report-timeline__headings-row> <th></th> <th class="c-report-timeline__headings-version p-article__color--dark">1</th> <th class="c-report-timeline__headings-version p-article__color--dark">2</th> </tr> </thead> <tbody> <tr class="c-report-timeline__row c-report-timeline__row--selected "> <th class=c-report-timeline__version> <a data-test-id=sidebar_timeline_v1_version href="https://f1000research.com/articles/6-2063/v1">Version 1</a><br/> <span class=p-article__color--dark> <span data-test-id=sidebar_timeline_v1_date class=c-report-timeline__date>29 Nov 17</span> </span> </th> <td class="c-report-timeline__report c-report-timeline__cell "> <i class="c-icn--f1r-icon c-icn--approved small" title=Approved #data-refInfo=""></i> </td> <td class="c-report-timeline__report c-report-timeline__cell "> <i class="c-icn--f1r-icon c-icn--approved small" title=Approved #data-refInfo=""></i> </td> </tr> </tbody> </table> <div class=o-layout__item> <hr class="c-hr c-hr--low u-mb--2"> </div> </section> </div> <div class=o-layout__item> <div class="u-pl u-pr"> <p class="t-body u-mt--0 u-mb--2"><a href="/browse/faculty-reviews">Faculty Reviews</a> are review articles written by the prestigious Members of <a href="https://facultyopinions.com/prime/home" target=_blank class=in-text-link>Faculty Opinions</a>. The articles are commissioned and peer reviewed before publication to ensure that the final, published version is comprehensive and accessible. The reviewers who approved the final version are listed with their names and affiliations.</p> <ol class="p-article__faculty-referee-list t-caption"> <li> <p class=" u-mt--0 u-mb--1/2"><strong>Cristina Hern&aacute;ndez</strong>, Diabetes and Metabolism Research Unit, Vall d'Hebron Research Institute, Universitat Autònoma de Barcelona, Spain </p> <div class="c-read-more js-read-more " data-lines=3> <div class="c-read-more__content js-read-more-content "> <p class="u-mt--0 u-mb--0 p-article__color--light"> <strong class=u-weight--md>Competing interests:</strong> No competing interests were declared. </p> </div> <a href="#" class="c-read-more__toggle js-read-more-toggle t-caption"> <span class=c-read-more__expand>View more</span> <span class=c-read-more__contract>View less</span> </a> </div> </li> <li> <p class=" u-mt--0 u-mb--1/2"><strong>Harry W Flynn</strong>, Department of Ophthalmology, Bascom Palmer Eye Institute, University of Miami Miller School of Medicine, USA </p> <div class="c-read-more js-read-more " data-lines=3> <div class="c-read-more__content js-read-more-content "> <p class="u-mt--0 u-mb--0 p-article__color--light"> <strong class=u-weight--md>Competing interests:</strong> No competing interests were declared. </p> </div> <a href="#" class="c-read-more__toggle js-read-more-toggle t-caption"> <span class=c-read-more__expand>View more</span> <span class=c-read-more__contract>View less</span> </a> </div> <p class=" u-mt--2 u-mb--1/2"><strong>Nidhi Relhan</strong>, Department of Ophthalmology, Bascom Palmer Eye Institute, University of Miami miller School of Medicine, USA </p> <div class="c-read-more js-read-more " data-lines=3> <div class="c-read-more__content js-read-more-content "> <p class="u-mt--0 u-mb--0 p-article__color--light"> <strong class=u-weight--md>Competing interests:</strong> No competing interests were declared. </p> </div> <a href="#" class="c-read-more__toggle js-read-more-toggle t-caption"> <span class=c-read-more__expand>View more</span> <span class=c-read-more__contract>View less</span> </a> </div> </li> </ol> </div> </div> <section class="o-layout__item u-pl"> <div class=u-pl> <hr class="c-hr c-hr--low c-hr--md u-mb--3"> <h4 class="t-h3 u-weight--md u-mt--0 u-mb--2">Comments on this article</h4> <div class=u-mb--4> <p class="u-mt--0 u-mb--1 t-h4"><a class=p-article__color--light href="#article-comments">All Comments</a><span class=" u-ib u-ml--1/2 p-article__color--light">(0)</span></p> <a class=t-h4 href="/login?originalPath=/articles/6-2063&scrollTo=add-new-comment" data-test-id=add-comment>Add a comment</a> </div> <hr class="c-hr c-hr--low c-hr--md u-mb--4"> <div class="research-layout f1r-article-desk"> <div class="heading6 c-ribbon-wrapper c-ribbon-wrapper--etoc f1000research "> <div class=c-ribbon-wrapper__body>Sign up for content alerts</div> </div> </div> <div class="research-layout sidebar-sign-up-form f1r-article-desk u-mb--4 "> <form class=js-email-alert-signup action="#" method=POST data-email=tocAlertWeekly> <input type=hidden name=isUserLoggedIn class=js-email-alert-signup-logged-in value=N /> <input type=hidden name=userId class=js-email-alert-signup-user-id value=""/> <input type=hidden name=frequency class=js-email-alert-signup-frequency value=WEEKLY /> <div class="o-actions o-actions--middle"> <div class=o-actions__primary> <input type=email name=emailAddress class="form-input-field js-email-alert-signup-address u-1/1 u-bb" required=required placeholder=Email /> </div> <div class=o-actions__secondary> <div class="_mdl-layout u-ml--1/2"> <button class="mdl-button mdl-js-button mdl-button--colored mdl-button--small mdl-button--filled js-email-alert-signup-submit">Sign Up</button> </div> </div> </div> </form> <div id=sidebar-sign-up-message class="section-text js-email-alert-signup-msg is-hidden">You are now signed up to receive this alert</div> </div> <section class=js-terms-container> <hr class="c-hr c-hr--low c-hr--md u-mb--3"> <h4 class="t-h3 u-weight--md u-mt--0 u-mb--1">Browse by related subjects</h4> <div class="article-subcontainer article-subcontainer--sidebar"> <ul class=js-terms-list></ul> </div> </section> </div> </section> </div> </section> </div> <script src="/js/shared_scripts/modal-dialogue.js"></script> <script src="/js/shared_scripts/read-more.js"></script> <script src="/js/article/article-router.js"></script> <script src="/js/article/article-sidebar.js"></script> <script src="/js/referee/new/referee_helpers.js"></script> <script src="/js/article/article-column-toggle.js"></script> </div> </div> </div> </main> <input type=hidden id=_articleVersionUrl value="https://f1000research.com/articles/6-2063/v1/"> <div class=research-help id=about-referee-status> <div class="research-layout research-help-content about-referee-status"> <span class="close-research-help dark-cross" title=Close></span> Alongside their report, reviewers assign a status to the article: <div class="cf research-help-row"> <span class="f1r-icon icon-86_approved status-green smaller" title=Approved></span> <span class=research-help-text>Approved - the paper is scientifically sound in its current form and only minor, if any, improvements are suggested</span> </div> <div class="cf research-help-row"> <span class="f1r-icon icon-87_approved_reservations status-green smaller" title="Approved with Reservations"></span> <span class=research-help-text>Approved with reservations - A number of small changes, sometimes more significant revisions are required to address specific details and improve the papers academic merit. </span> </div> <div class="cf research-help-row"> <span class="f1r-icon icon-88_not_approved status-red small" title="Not Approved"></span> <span class=research-help-text>Not approved - fundamental flaws in the paper seriously undermine the findings and conclusions</span> </div> </div> </div> <div id=datasets-info class=is-hidden> </div> <div class=article-interactive-content-container style="display: none;"> <a name=f-template class=n-a></a> <div class="interactive-content-wrapper padding-20"> <img src="" class=interactive-content-image title="Open the interactive image display"> <div class=interactive-content-title></div> <div class=interactive-content-text></div> <div class="f1r-article-desk interactive-content-ribbon" data-interactive-content-type=R-Script> <div class=interactive-content-label>Adjust parameters to alter display</div> <div class=interactive-content-button></div> </div> <div class="f1r-article-mobile mobile-interactive-note"> View on desktop for interactive features <img src="/img/icon/interactive_content.png" class="float-right margin-right-40"/> </div> <div class=clearfix></div> </div> </div> <div id=article-interactive-omero-container class=article-interactive-omero-container style="display: none;"> <div class=interactive-content-wrapper> <div class="interactive-omero-button omero-content" title="Open the interactive content window." data-interactive-content-type=Omero></div> <div class=has-interactive-content-image> <span class=box-arrow></span> <span class=box-middle>Includes Interactive Elements</span> <span class=box-end></span> </div> <div class="fig panel clearfix" style="margin: 0; padding-bottom: 20px;"> <a name=templatelink class=n-a></a> <a target=_blank href="" class=link-for-omero-image> <img src="" class=interactive-omero-image title="Open the image display window."> </a> <div class=caption> <div class=interactive-content-title></div> <div class=interactive-content-text></div> </div> <div class="is-hidden omero-image-list"></div> </div> <div class="f1r-article-mobile mobile-interactive-note omero"> View on desktop for interactive features <img src="/img/icon/interactive_content.png" class="float-right margin-right-40"/> </div> <div class=clearfix></div> </div> </div> <div class="add-comment-container shadow-box is-hidden" id=save-comment-container> <span id=save-comment-text class=intro-text>Edit comment</span> <textarea id=new-comment name=new-comment class="global-textarea comment margin-bottom margin-top"></textarea> <p><strong>Competing Interests</strong></p> <textarea id=new-competing-interests name=competing-interests class="global-textarea competing-interests margin-bottom check-xss"></textarea> <div class=clearfix></div> <button id=cancelComment type=button class="general-white-orange-button float-right no-background-button margin-left"> Cancel </button> <button id=save-comment-button commentId="" type=button class="general-white-orange-button float-right"> Save </button> <div class=clearfix></div> <div class="green-message margin-top is-hidden comment-is-saved">The comment has been saved.</div> <div class="red-message margin-top is-hidden comment-not-added">An error has occurred. Please try again.</div> <div class="red-message margin-top is-hidden comment-enter-text ucf">Your must enter a comment.</div> <div class="red-message margin-top is-hidden comment-references-error references">References error.</div> </div> <div class="modal-window-wrapper is-hidden"> <div id=conflicts-interests class="modal-window padding-20"> <div class=modal-window__content> <h2 class=h2-title>Competing Interests Policy</h2> <p> Provide sufficient details of any financial or non-financial competing interests to enable users to assess whether your comments might lead a reasonable person to question your impartiality. Consider the following examples, but note that this is not an exhaustive list: </p> <div class=heading5>Examples of 'Non-Financial Competing Interests'</div> <ol class="numbered-list no-padding"> <li class=standard-padding>Within the past 4 years, you have held joint grants, published or collaborated with any of the authors of the selected paper.</li> <li class=standard-padding>You have a close personal relationship (e.g. parent, spouse, sibling, or domestic partner) with any of the authors.</li> <li class=standard-padding>You are a close professional associate of any of the authors (e.g. scientific mentor, recent student).</li> <li class=standard-padding>You work at the same institute as any of the authors.</li> <li class=standard-padding>You hope/expect to benefit (e.g. favour or employment) as a result of your submission.</li> <li class=standard-padding>You are an Editor for the journal in which the article is published.</li> </ol> <div class="heading5 padding-top">Examples of 'Financial Competing Interests'</div> <ol class="numbered-list no-padding"> <li class=standard-padding>You expect to receive, or in the past 4 years have received, any of the following from any commercial organisation that may gain financially from your submission: a salary, fees, funding, reimbursements.</li> <li class=standard-padding>You expect to receive, or in the past 4 years have received, shared grant support or other funding with any of the authors.</li> <li class=standard-padding>You hold, or are currently applying for, any patents or significant stocks/shares relating to the subject matter of the paper you are commenting on.</li> </ol> </div> <div class="f1r-article-mobile research-layout"> <span class=modal-window-close-button></span> </div> </div> </div> <div class="o-modal c-email-alert-popup js-email-alert-popup is-hidden"> <div class="o-modal__body js-modal-body c-email-alert-popup__inner"> <h3 class=c-email-alert-popup__title>Stay Updated</h3> <p class=c-email-alert-popup__sub>Sign up for content alerts and receive a weekly or monthly email with all newly published articles</p> <p><a href="/register?originalPath=" class="c-email-alert-popup__lnk c-email-alert-popup__button js-email-alert-popup-action">Register with F1000Research</a></p> <p>Already registered? <a href="/login?originalPath=" class="c-email-alert-popup__lnk js-email-alert-popup-action">Sign in</a></p> <p class=c-email-alert-popup__footer><a class="c-email-alert-popup__lnk js-email-alert-popup-cancel" href="#">Not now, thanks</a></p> </div> </div> <div id=addCommentModal role=dialog aria-labelledby=addCommentModal_title aria-describedby=addCommentModal_description> <div class="c-modal js-modal is-closed p-article__add-comment-modal c-modal--xlarge js-article-comment-modal c-modal--scroll "> <aside class="c-modal__content u-black--high o-box u-pb--0 u-bg--2 c-modal--scroll-always "> <div class=c-modal__close> <button type=button class="c-button c-button--icon c-button--medium c-button--full@hover js-modal__close"><i class="c-button--icon__icon material-icons">close</i></button> </div> <div id=addCommentModal_description class="c-modal__description js-modal__content t-h4 u-mt--0 u-mb--2 u-black--medium"> <div class="js-add-comment-container t-caption u-black--high"> <div class=u-weight--bd>PLEASE NOTE</div> <div class=u-mt--1> <span class="red u-weight--bd">If you are an AUTHOR of this article,</span> please check that you signed in with the account associated with this article otherwise we cannot automatically identify your role as an author and your comment will be labelled as a &ldquo;User Comment&rdquo;. </div> <div class=u-mt--1> <span class="red u-weight--bd">If you are a REVIEWER of this article,</span> please check that you have signed in with the account associated with this article and then go to your <a href="/my/referee">account</a> to submit your report, please do not post your review here. </div> <div class="u-mt--1 u-mb--1"> If you do not have access to your original account, please <a href="mailto:research@f1000.com">contact us</a>. </div> <p class=no-top-margin>All commenters must hold a formal affiliation as per our <a href="/about/policies#commentspolicy" target=_blank>Policies</a>. The information that you give us will be displayed next to your comment.</p> <p>User comments must be in English, comprehensible and relevant to the article under discussion. We reserve the right to remove any comments that we consider to be inappropriate, offensive or otherwise in breach of the <a href="/about/legal/usercommenttermsandconditions" target=_blank>User Comment Terms and Conditions</a>. Commenters must not use a comment for personal attacks. When criticisms of the article are based on unpublished data, the data should be made available.</p> <div class="comments-note margin-bottom" id=accept-user-comments> <input class=js-add-comment-accept-terms type=checkbox id=acceptedTermsAndConditions name=acceptedTermsAndConditions> I accept the <a href="/about/legal/usercommenttermsandconditions" target=_blank> User Comment Terms and Conditions</a> <span class=required>&nbsp;</span> </div> <div class="default-error margin-top is-hidden comment-accept-conditions utac">Please confirm that you accept the User Comment Terms and Conditions.</div> <div class="research-layout registration-form u-mb--2"> <div class="u-mb--1 u-mt--2"> <strong>Affiliation</strong> </div> <div class=form-field> <input type=text name=institution class="form-input-field check-xss js-add-comment-institution" placeholder="Organization *" autocomplete=off /> <div class="default-error margin-top is-hidden comment-enter-institution institution">Please enter your organisation.</div> </div> <div class=form-field> <input type=text name=place class="form-input-field check-xss js-add-comment-place" placeholder=Place> </div> <div class=form-field> <div class="form-input-wrapper hundred-percent-wide"> <div class="new-select-standard-wrapper half-width inline-display heading10"> <select name=countryId id=country class="form-select-menu smaller js-add-comment-country"> <option value=-1>Country*</option> <option value=840>USA</option> <option value=826>UK</option> <option value=124>Canada</option> <option value=156>China</option> <option value=250>France</option> <option value=276>Germany</option> <optgroup label=-----------------------------------------------></optgroup> <option value=4>Afghanistan</option> <option value=248>Aland Islands</option> <option value=8>Albania</option> <option value=12>Algeria</option> <option value=16>American Samoa</option> <option value=20>Andorra</option> <option value=24>Angola</option> <option value=660>Anguilla</option> <option value=10>Antarctica</option> <option value=28>Antigua and Barbuda</option> <option value=32>Argentina</option> <option value=51>Armenia</option> <option value=533>Aruba</option> <option value=36>Australia</option> <option value=40>Austria</option> <option value=31>Azerbaijan</option> <option value=44>Bahamas</option> <option value=48>Bahrain</option> <option value=50>Bangladesh</option> <option value=52>Barbados</option> <option value=112>Belarus</option> <option value=56>Belgium</option> <option value=84>Belize</option> <option value=204>Benin</option> <option value=60>Bermuda</option> <option value=64>Bhutan</option> <option value=68>Bolivia</option> <option value=70>Bosnia and Herzegovina</option> <option value=72>Botswana</option> <option value=74>Bouvet Island</option> <option value=76>Brazil</option> <option value=86>British Indian Ocean Territory</option> <option value=92>British Virgin Islands</option> <option value=96>Brunei</option> <option value=100>Bulgaria</option> <option value=854>Burkina Faso</option> <option value=108>Burundi</option> <option value=116>Cambodia</option> <option value=120>Cameroon</option> <option value=124>Canada</option> <option value=132>Cape Verde</option> <option value=136>Cayman Islands</option> <option value=140>Central African Republic</option> <option value=148>Chad</option> <option value=152>Chile</option> <option value=156>China</option> <option value=162>Christmas Island</option> <option value=166>Cocos (Keeling) Islands</option> <option value=170>Colombia</option> <option value=174>Comoros</option> <option value=178>Congo</option> <option value=184>Cook Islands</option> <option value=188>Costa Rica</option> <option value=384>Cote d'Ivoire</option> <option value=191>Croatia</option> <option value=192>Cuba</option> <option value=196>Cyprus</option> <option value=203>Czech Republic</option> <option value=180>Democratic Republic of the Congo</option> <option value=208>Denmark</option> <option value=262>Djibouti</option> <option value=212>Dominica</option> <option value=214>Dominican Republic</option> <option value=218>Ecuador</option> <option value=818>Egypt</option> <option value=222>El Salvador</option> <option value=226>Equatorial Guinea</option> <option value=232>Eritrea</option> <option value=233>Estonia</option> <option value=231>Ethiopia</option> <option value=238>Falkland Islands</option> <option value=234>Faroe Islands</option> <option value=583>Federated States of Micronesia</option> <option value=242>Fiji</option> <option value=246>Finland</option> <option value=250>France</option> <option value=254>French Guiana</option> <option value=258>French Polynesia</option> <option value=260>French Southern Territories</option> <option value=266>Gabon</option> <option value=268>Georgia</option> <option value=276>Germany</option> <option value=288>Ghana</option> <option value=292>Gibraltar</option> <option value=300>Greece</option> <option value=304>Greenland</option> <option value=308>Grenada</option> <option value=312>Guadeloupe</option> <option value=316>Guam</option> <option value=320>Guatemala</option> <option value=831>Guernsey</option> <option value=324>Guinea</option> <option value=624>Guinea-Bissau</option> <option value=328>Guyana</option> <option value=332>Haiti</option> <option value=334>Heard Island and Mcdonald Islands</option> <option value=336>Holy See (Vatican City State)</option> <option value=340>Honduras</option> <option value=344>Hong Kong</option> <option value=348>Hungary</option> <option value=352>Iceland</option> <option value=356>India</option> <option value=360>Indonesia</option> <option value=364>Iran</option> <option value=368>Iraq</option> <option value=372>Ireland</option> <option value=376>Israel</option> <option value=380>Italy</option> <option value=388>Jamaica</option> <option value=392>Japan</option> <option value=832>Jersey</option> <option value=400>Jordan</option> <option value=398>Kazakhstan</option> <option value=404>Kenya</option> <option value=296>Kiribati</option> <option value=901>Kosovo (Serbia and Montenegro)</option> <option value=414>Kuwait</option> <option value=417>Kyrgyzstan</option> <option value=418>Lao People's Democratic Republic</option> <option value=428>Latvia</option> <option value=422>Lebanon</option> <option value=426>Lesotho</option> <option value=430>Liberia</option> <option value=434>Libya</option> <option value=438>Liechtenstein</option> <option value=440>Lithuania</option> <option value=442>Luxembourg</option> <option value=446>Macao</option> <option value=807>Macedonia</option> <option value=450>Madagascar</option> <option value=454>Malawi</option> <option value=458>Malaysia</option> <option value=462>Maldives</option> <option value=466>Mali</option> <option value=470>Malta</option> <option value=584>Marshall Islands</option> <option value=474>Martinique</option> <option value=478>Mauritania</option> <option value=480>Mauritius</option> <option value=175>Mayotte</option> <option value=484>Mexico</option> <option value=581>Minor Outlying Islands of the United States</option> <option value=498>Moldova</option> <option value=492>Monaco</option> <option value=496>Mongolia</option> <option value=499>Montenegro</option> <option value=500>Montserrat</option> <option value=504>Morocco</option> <option value=508>Mozambique</option> <option value=104>Myanmar</option> <option value=516>Namibia</option> <option value=520>Nauru</option> <option value=524>Nepal</option> <option value=530>Netherlands Antilles</option> <option value=540>New Caledonia</option> <option value=554>New Zealand</option> <option value=558>Nicaragua</option> <option value=562>Niger</option> <option value=566>Nigeria</option> <option value=570>Niue</option> <option value=574>Norfolk Island</option> <option value=580>Northern Mariana Islands</option> <option value=408>North Korea</option> <option value=578>Norway</option> <option value=512>Oman</option> <option value=586>Pakistan</option> <option value=585>Palau</option> <option value=275>Palestinian Territory</option> <option value=591>Panama</option> <option value=598>Papua New Guinea</option> <option value=600>Paraguay</option> <option value=604>Peru</option> <option value=608>Philippines</option> <option value=612>Pitcairn</option> <option value=616>Poland</option> <option value=620>Portugal</option> <option value=630>Puerto Rico</option> <option value=634>Qatar</option> <option value=638>Reunion</option> <option value=642>Romania</option> <option value=643>Russian Federation</option> <option value=646>Rwanda</option> <option value=654>Saint Helena</option> <option value=659>Saint Kitts and Nevis</option> <option value=662>Saint Lucia</option> <option value=666>Saint Pierre and Miquelon</option> <option value=670>Saint Vincent and the Grenadines</option> <option value=882>Samoa</option> <option value=674>San Marino</option> <option value=678>Sao Tome and Principe</option> <option value=682>Saudi Arabia</option> <option value=686>Senegal</option> <option value=688>Serbia</option> <option value=690>Seychelles</option> <option value=694>Sierra Leone</option> <option value=702>Singapore</option> <option value=703>Slovakia</option> <option value=705>Slovenia</option> <option value=90>Solomon Islands</option> <option value=706>Somalia</option> <option value=710>South Africa</option> <option value=239>South Georgia and the South Sandwich Is</option> <option value=410>South Korea</option> <option value=724>Spain</option> <option value=144>Sri Lanka</option> <option value=736>Sudan</option> <option value=740>Suriname</option> <option value=744>Svalbard and Jan Mayen</option> <option value=748>Swaziland</option> <option value=752>Sweden</option> <option value=756>Switzerland</option> <option value=760>Syria</option> <option value=158>Taiwan</option> <option value=762>Tajikistan</option> <option value=834>Tanzania</option> <option value=764>Thailand</option> <option value=270>The Gambia</option> <option value=528>The Netherlands</option> <option value=626>Timor-Leste</option> <option value=768>Togo</option> <option value=772>Tokelau</option> <option value=776>Tonga</option> <option value=780>Trinidad and Tobago</option> <option value=788>Tunisia</option> <option value=792>Turkey</option> <option value=795>Turkmenistan</option> <option value=796>Turks and Caicos Islands</option> <option value=798>Tuvalu</option> <option value=800>Uganda</option> <option value=826>UK</option> <option value=804>Ukraine</option> <option value=784>United Arab Emirates</option> <option value=850>United States Virgin Islands</option> <option value=858>Uruguay</option> <option value=840>USA</option> <option value=860>Uzbekistan</option> <option value=548>Vanuatu</option> <option value=862>Venezuela</option> <option value=704>Vietnam</option> <option value=876>Wallis and Futuna</option> <option value=905>West Bank and Gaza Strip</option> <option value=732>Western Sahara</option> <option value=887>Yemen</option> <option value=894>Zambia</option> <option value=716>Zimbabwe</option> </select> </div> </div> <div class="default-error margin-top is-hidden comment-enter-country country">Please select your country.</div> </div> </div> <textarea data-test-id=article_add-comment_comment name=new-comment class="js-add-comment-comment comment margin-bottom margin-top"></textarea> <div class="default-error margin-top comment-enter-text comment-error is-hidden ">You must enter a comment.</div> <label class="comments-note u-mt--2 u-mb--2" for=competingInterests_1> <div class="u-mb--1 u-mt--2"><strong data-test-id=article_report-add-comment_competing-interests-title>Competing Interests</strong></div> <p class="u-mb--2 u-mt--0" data-test-id=article_report-add-comment_competing-interests-description>Please disclose any <a href="#article-competing-intersts-policy" class=js-modal-competing-intersts-toggle>competing interests</a> that might be construed to influence your judgment of the article's or peer review report's validity or importance.</p> </label> <div id=article-competing-intersts-policy class=js-article-competing-interests-policy style="display: none;"> <h2 class="h2-title u-mt--0 u-pt--0">Competing Interests Policy</h2> <p> Provide sufficient details of any financial or non-financial competing interests to enable users to assess whether your comments might lead a reasonable person to question your impartiality. Consider the following examples, but note that this is not an exhaustive list: </p> <div class=heading5>Examples of 'Non-Financial Competing Interests'</div> <ol class="numbered-list no-padding"> <li class=standard-padding>Within the past 4 years, you have held joint grants, published or collaborated with any of the authors of the selected paper.</li> <li class=standard-padding>You have a close personal relationship (e.g. parent, spouse, sibling, or domestic partner) with any of the authors.</li> <li class=standard-padding>You are a close professional associate of any of the authors (e.g. scientific mentor, recent student).</li> <li class=standard-padding>You work at the same institute as any of the authors.</li> <li class=standard-padding>You hope/expect to benefit (e.g. favour or employment) as a result of your submission.</li> <li class=standard-padding>You are an Editor for the journal in which the article is published.</li> </ol> <div class="heading5 padding-top">Examples of 'Financial Competing Interests'</div> <ol class="numbered-list no-padding"> <li class=standard-padding>You expect to receive, or in the past 4 years have received, any of the following from any commercial organisation that may gain financially from your submission: a salary, fees, funding, reimbursements.</li> <li class=standard-padding>You expect to receive, or in the past 4 years have received, shared grant support or other funding with any of the authors.</li> <li class=standard-padding>You hold, or are currently applying for, any patents or significant stocks/shares relating to the subject matter of the paper you are commenting on.</li> </ol> </div> <div id=competingInterests_1 class="c-inline-editor js-inline-editor js-form_input u-bb--all u-mb--2 js-comment-competing-interests" data-name=competing-interests data-rows=3> <textarea id=competingInterests_1_input name=competing-interests placeholder="&nbsp;" required=false class="u-hide-visually js-inline-editor_input" tabindex=-1></textarea> <div class="c-inline-editor__editor js-inline-editor_editor o-box c-box o-box--tiny u-bg--11" data-target=competingInterests_1_input role=textbox required=false data-placeholder="&nbsp;" contenteditable=true></div> <span class="c-inline-editor__error js-inline-editor-message">Please state your competing interests</span> </div> <div data-test-id=article_add-comment_saved class="green-message comments is-hidden comment-is-saved">The comment has been saved.</div> <div data-test-id=article_add-comment_error class="default-error comments is-hidden comment-not-added">An error has occurred. Please try again.</div> <div class=clearfix></div> <div class=js-hook></div> </div> <div class="c-modal__extra-message js-modal__extra-message t-h4 u-black--medium"></div></div> <div class="c-modal__actions o-box__actions"> <a href="#" data-test-id=article_add-comment_cancel class="c-button c-button--full js-modal__close c-button--secondary">Cancel</a> <a href="#" data-test-id=article_add-comment_post class="c-button c-button--full js-modal__confirm c-button--primary">Post</a> </div> </aside> </div> </div> <style>
                .at-icon-wrapper {
        background-size: 100% !important;
    }
</style> <script src="/js/namespace.js"></script> <script src="/js/constants.js"></script> <script src="/js/utilities.js"></script> <script src="/js/article/alert-signup.js"></script> <script type='text/javascript'>
    var lTitle = "Recent advances in the management and understanding...".replace("'", '');
    var linkedInUrl = "http://www.linkedin.com/shareArticle?url=https://f1000research.com/articles/6-2063/v1" + "&title=" + encodeURIComponent(lTitle) + "&summary=" + encodeURIComponent('Read the article by ');

    var deliciousUrl = "https://del.icio.us/post?url=https://f1000research.com/articles/6-2063/v1&title=" + encodeURIComponent(lTitle);

    var redditUrl = "http://reddit.com/submit?url=https://f1000research.com/articles/6-2063/v1" + "&title=" + encodeURIComponent(lTitle);

            linkedInUrl += encodeURIComponent('Powers M et al.');
    
    var offsetTop = /chrome/i.test( navigator.userAgent ) ? 4 : -10; 
    var addthis_config = {
            ui_offset_top: offsetTop,
                                    services_compact : "facebook,twitter,www.linkedin.com,www.mendeley.com,reddit.com",
            services_expanded : "facebook,twitter,www.linkedin.com,www.mendeley.com,reddit.com",
            services_custom : [
                {
                    name: "LinkedIn",
                    url:  linkedInUrl,
                    icon:"/img/icon/at_linkedin.svg"
                },
                {
                    name: "Mendeley",
                    url:  "http://www.mendeley.com/import/?url=https://f1000research.com/articles/6-2063/v1/mendeley",
                    icon:"/img/icon/at_mendeley.svg"
                },
                {
                    name: "Reddit",
                    url:  redditUrl,
                    icon:"/img/icon/at_reddit.svg"
                },
            ]
        };


    var addthis_share = {
            url: "https://f1000research.com/articles/6-2063",
            templates : {
                twitter : "Recent advances in the management and understanding of diabetic.... Powers M et al., published by " + 
               "@F1000Research"
       + ", https://f1000research.com/articles/6-2063/v1"
            }
        };

    if (typeof(addthis) != "undefined"){
        addthis.addEventListener('addthis.ready', checkCount);
        addthis.addEventListener('addthis.menu.share', checkCount);
    }

        $(".f1r-shares-twitter").attr("href", "https://twitter.com/intent/tweet?text=" + addthis_share.templates.twitter);
    $(".f1r-shares-facebook").attr("href", "https://www.facebook.com/sharer/sharer.php?u=" + addthis_share.url);
    $(".f1r-shares-linkedin").attr("href", addthis_config.services_custom[0].url);
    $(".f1r-shares-reddit").attr("href", addthis_config.services_custom[2].url);
    $(".f1r-shares-mendelay").attr("href", addthis_config.services_custom[1].url);

    function checkCount(){
        setTimeout(function(){
            $(".addthis_button_expanded").each(function(){
                var count = $(this).text();
                if (count !== "" && count != "0")
                    $(this).removeClass("is-hidden");
                else
                    $(this).addClass("is-hidden");
            });
        }, 1000);
    }
</script> <div id=citeReportModal role=dialog aria-labelledby=citeReportModal_title aria-describedby=citeReportModal_description> <div class="c-modal js-modal is-closed c-modal--large js-cite-report-modal "> <aside class="c-modal__content u-black--high o-box u-pb--0 u-black--high "> <div class=c-modal__close> <button type=button class="c-button c-button--icon c-button--medium c-button--full@hover js-modal__close"><i class="c-button--icon__icon material-icons">close</i></button> </div> <h1 id=citeReportModal_title class="c-modal__title t-h3 u-mt--0 u-mb--2 u-weight--md">How to cite this report</h1> <div id=citeReportModal_description class="c-modal__description js-modal__content t-h4 u-mt--0 u-mb--2 u-black--medium"> <div id="" class=js-report-citation-container>{{reportCitation}}</div> <div class="c-modal__extra-message js-modal__extra-message t-h4 u-black--medium"></div></div> <div class="c-modal__actions o-box__actions"> <a href="#" class="c-button c-button--full js-modal__close c-button--secondary">Cancel</a> <a href="#" title="Copy the current citation details to the clipboard." data-clipboard-target="#referee-report-citation" data-test-id=report_copy-citation_button class="c-button c-button--full js-modal__confirm c-button--primary js-clipboard c-mini-tooltip--above">Copy Citation Details</a> </div> </aside> </div> </div> <script src="/js/referee/new/referee_validators.js"></script> <script src="/js/referee/new/referee_helpers.js"></script> <script src="/js/referee/new/referee_checkbox-input.js"></script> <script src="/js/referee/new/referee_inline-editor.js"></script> <script type="text/javascript">
    $(function(){
        var gaCat = "F1000Research";
        if (gaCat === "") {
            gaCat = $("body").hasClass("wellcome-brand") ? "Wellcome Open Research" : "F1000Research";
        }
        GAHelper.track({category: gaCat, action: "Article Page: Recent advances in the management and understanding of diabetic retinopathy", label: "pageviews"});
        GAHelper.track({category: gaCat, action: "Article Type: Review", label: "Article Page"});
        $(".f1r-article-desk .collection-image").each(function (idx, el) {
            var whatChannel = $(el).find("a").attr("href"),
                channelName = $.trim($(el).parent().find(".collection-detail a").text()),
                gaRef = "(ID: " + whatChannel.replace("/collections/", "") + ") " + channelName;
            GAHelper.track({category: 'ChannelStats', action: "Article Page: Recent advances in the management and understanding of diabetic retinopathy", label: gaRef});
        });
    });
</script> <script>
    $(function(){R.ui.buttonDropdowns('.dropdown-for-downloads');});
    $(function(){R.ui.toolbarDropdowns('.toolbar-dropdown-for-downloads');});
</script> <script src="/js/article/track_article.js" type="text/javascript"></script> <script type="text/javascript">
    $.get("/articles/acj/12662/13709")
</script> <script type="text/javascript" src="https://d1bxh8uas1mnw7.cloudfront.net/assets/embed.js"></script> <script type="text/javascript" src="/js/app/messenger.js"></script> <script type="text/javascript" src="/js/article/article_mobiles.js"></script> <script src="/js/vendor/clipboard.min.js"></script> <script src="/js/shared_scripts/modal-dialogue.js"></script> <script src="/js/shared_scripts/clipboard.js"></script> <script src="/js/article/thesaurus-terms-display.js"></script> <script>
    new F1000.Clipboard();
    new F1000.ThesaurusTermsDisplay("faculty-reviews", "article", "13709");
</script> <script>
    $(document).ready(function() {
        $( "#frame1" ).on('load', function() {
            var mydiv = $(this).contents().find("div");
            var h     = mydiv.height();
            console.log(h)
        });

        
        var tooltipLivingFigure = jQuery(".interactive-living-figure-label .icon-more-info"),
            titleLivingFigure = tooltipLivingFigure.attr("title");
        tooltipLivingFigure.simpletip({
            fixed: true,
            position: ["-115", "30"],
            baseClass: 'small-tooltip',
            content:titleLivingFigure + "<div class='tooltip-arrow'></div>"
        });
        tooltipLivingFigure.removeAttr("title");

        $("body").on("click", ".cite-living-figure", function(e) {
            e.preventDefault();
            var ref = $(this).attr("data-ref");
            $(this).closest(".living-figure-list-container").find("#" + ref).fadeIn(200);
        });
        $("body").on("click", ".close-cite-living-figure", function(e) {
            e.preventDefault();
            $(this).closest(".popup-window-wrapper").fadeOut(200);
        });

                $(document).on("mouseup", function(e) {
            var metricsContainer = $(".article-metrics-popover-wrapper");
            if (!metricsContainer.is(e.target) && metricsContainer.has(e.target).length === 0) {
                $(".article-metrics-close-button").click();
            }
        });

        var articleId = $('#articleId').val();

        if($("#main-article-count-box").attachArticleMetrics) {
            $("#main-article-count-box").attachArticleMetrics(articleId, {
                articleMetricsView: true
            });
        }
    });

    var figshareWidget = $(".new_figshare_widget");
    if (figshareWidget.length > 0) {
        window.figshare.load("f1000", function(Widget) {
            // Select a tag/tags defined in your page. In this tag we will place the widget.
            _.map(figshareWidget, function(el){
                var widget = new Widget({
                    articleId: $(el).attr("figshare_articleId")
                    //height:300 // this is the height of the viewer part. [Default: 550]
                });
                widget.initialize(); // initialize the widget
                widget.mount(el); // mount it in a tag that's on your page
                // this will save the widget on the global scope for later use from
                // your JS scripts. This line is optional.
                //window.widget = widget;
            });
        });
    }
</script>

<script>
    $(document).ready(function () {

        
        var reportIds = {
                           "28275": 0,
                           "28276": 0,
                    };

        $(".referee-response-container,.js-referee-report").each(function(index, el) {
            var reportId = $(el).attr("data-reportid"),
                reportCount = reportIds[reportId] || 0;
            $(el).find(".comments-count-container,.js-referee-report-views").html(reportCount);
        });

        var uuidInput = $("#article_uuid"),
            oldUUId = uuidInput.val(),
            newUUId = "57c3d611-aa81-4c77-b9b3-083a263f586b";
        uuidInput.val(newUUId);

        $("a[href*='article_uuid=']").each(function(index, el) {
            var newHref = $(el).attr("href").replace(oldUUId, newUUId);
            $(el).attr("href", newHref);
        });

    });
</script>              </div>
        </div>

        
            
            <div class="o-page__footer sticky-email-wrapper">
                
                

                


<footer class="c-footer t-inverted">

    <div class="o-wrapper">
        <div class="o-layout">


                        
            <div class="o-layout__item u-mb--3">
                <div class="c-branding c-branding--research">
                    <img src="/img/research/F1000Research_white.svg" alt="F1000Research">
                </div>
            </div>


                        
            <div class="o-layout__item u-1/3@md u-mb--3">

                <span class="c-hr c-hr--thick c-hr--low u-mb--2"></span>

                <p class="t-h3 u-mt--0 u-mb--0">An innovative open access publishing platform offering rapid publication and open peer review, whilst supporting data deposition and sharing.</p>

            </div>


                        
            <div class="o-layout__item u-2/3@md">

                <span class="c-hr c-hr--thick c-hr--low u-mb--2"></span>

                <div class="o-layout">
                    <nav class="c-footer__nav">

                            <div class="o-layout__item u-3/5@sm u-mb--3">


                                <div class="o-columns o-columns--2">

                                                                            <a href="/browse/articles" class="t-body c-footer__nav-item "      >Browse</a>
                                                                            <a href="/gateways" class="t-body c-footer__nav-item "      >Gateways</a>
                                                                            <a href="/collections" class="t-body c-footer__nav-item "      >Collections</a>
                                                                            <a href="/about" class="t-body c-footer__nav-item "      >How it Works</a>
                                                                            <a href="https://blog.f1000.com/blogs/f1000research/" class="t-body c-footer__nav-item "      >Blog</a>
                                                                            <a href="/contact" class="t-body c-footer__nav-item "      >Contact</a>
                                                                            <a href="/developers" class="t-body c-footer__nav-item u-hide u-show@navbar"      >For Developers</a>
                                                                            <a href="/published/rss" class="t-body c-footer__nav-item "   title="RSS feed of published articles"     >RSS</a>
                                    
                                </div>

                            </div>

                            <div class="o-layout__item u-2/5@sm u-center u-right@sm u-mb--3">

                                <div class="u-hide u-show@lg">
                                    <div class="_mdl-layout">
                                        <a class="mdl-button mdl-js-button mdl-button--inverted mdl-button--no-shadow mdl-js-ripple-effect mdl-button--outline" href="/for-authors/publish-your-research"   data-test-id="footer_submit_research"  >Submit Your Research</a>
                                    </div>
                                </div>

                            </div>

                    </nav>
                </div>

            </div>

            <div class="o-layout__item u-mb--2">
                <div class="c-footer__share">
                        <div class="c-footer__share">
        <span class="c-footer__share-icon" title="Open Access">
            <span class="f1r-icon icon-100_open_access license-icon"></span>
        </span>

        <a class="c-footer__share-icon" href="//creativecommons.org/licenses" target="_blank" title="Creative Commons License CC-BY">
            <span class="f1r-icon icon-116_cc license-icon license-icon-cc"></span>
            <span class="f1r-icon icon-117_ccby license-icon license-icon-cc"></span>
        </a>

        <a class="c-footer__share-icon" href="//creativecommons.org/about/cc0" target="_blank" title="Creative Commons License CC0">
            <span class="f1r-icon icon-118_cco license-icon"></span>
        </a>

    </div>
                </div>
            </div>


                        
            <div class="o-layout__item u-1/3@md u-mb--3">

                <span class="c-hr c-hr--low u-mb--3"></span>

                <p class="c-footer__social u-mt--0 u-mb--0 u-white--low-med">Follow us
                    <a href="https://www.facebook.com/F1000" target="_blank" class="c-footer__social-icon f1r-icon icon-55_footer_facebook"></a>
                    <a href="https://twitter.com/#!/F1000Research" target="_blank" class="c-footer__social-icon f1r-icon icon-56_footer_twitter"></a>
                    <a href="http://www.youtube.com/user/F1000research" target="_blank" class="c-footer__social-icon f1r-icon icon-57_footer_youtube"></a></p>

            </div>


                        
            <div class="o-layout__item u-2/3@md u-right@md">

                <span class="c-hr c-hr--low u-mb--3"></span>

                <p class="t-caption u-white--low-med">&copy; 2012-2020 F1000 Research Ltd. ISSN 2046-1402 | <a href="/about/legal" class="copyrightLegal">Legal</a> | Partner of <a target="_blank" href="http://www.who.int/hinari/en/">HINARI</a>  &bull; <a target="_blank" href="http://crossref.org/">CrossRef</a> &bull; <a target="_blank" href="http://about.orcid.org/">ORCID</a> &bull; <a target="_blank" href="http://www.fairsharing.org">FAIRSharing</a></p>

            </div>
        </div>
    </div>

</footer>            </div>
        
    </div>

            <div class="js-cookie-spacer"></div>
        <div class="cookie-warning">
            <div class="instruction">The F1000Research website uses cookies. By continuing to browse the site, you are agreeing to our use of cookies. <a class="js-scroll-to" href="/about/legal/privacypolicy#use-of-cookies" data-scroll-target="#use-of-cookies">Find out more &raquo;</a></div>
            <div class="close-button"></div>
        </div>
    
    <script>
                    R.templateTests.simpleTemplate = R.template('<p class="$variable.one">$text</p><p class="${variable.two}">$text</p><p class="$!variable.three">$text</p><p class="$!{variable.four}">$text</p><p class="${selector}.five">$text</p>');
            R.templateTests.runTests();
        
        var F1000platform = new F1000.Platform({
            name: "f1000research",
            displayName: "F1000Research",
            hostName: "f1000research.com",
            id: "1",
            editorialEmail: "research@f1000.com",
            infoEmail: "info@f1000.com",
            usePmcStats: true
        });

                    $(function(){R.ui.dropdowns('.dropdown-for-authors, .dropdown-for-about, .dropdown-for-myresearch');});
            // $(function(){R.ui.dropdowns('.dropdown-for-referees');});

            $(document).ready(function () {
                if ($(".cookie-warning").is(":visible")) {
                    $(".sticky").css("margin-bottom", "35px");
                    $(".devices").addClass("devices-and-cookie-warning");
                }
                $(".cookie-warning .close-button").click(function (e) {
                    $(".devices").removeClass("devices-and-cookie-warning");
                    $(".sticky").css("margin-bottom", "0");
                });

                $("#tweeter-feed .tweet-message").each(function (i, message) {
                    var self = $(message);
                    self.html(linkify(self.html()));
                });

                $(".partner").on("mouseenter mouseleave", function() {
                    $(this).find(".gray-scale, .colour").toggleClass("is-hidden");
                });
            });
        
    </script>

            
<div class="sign-in-popup">
	<!-- <a href="#" class="sign-in shadow">Sign in <span class="sign-in-image-active"></span></a> -->
	<a href="#" class="sign-in ${locale}">Sign In <span class="arrow-closed sign-in-arrow-padding arrow-opened"></span></a>
	<div class="sign-in-form">

            <form action="https://f1000research.com/j_spring_oauth_security_check" id="googleOAuth" method="post"  target="_top" >
                                    <input class="target-field" type="hidden" name="target" value="/articles/6-2063.html"/>
                            <input id="google-remember-me" name="_spring_security_oauth_remember_me" type="hidden" value="true"/>
        <input id="system-google" name="system" type="hidden" value="GOOGLE"/>
    </form>
            <form action="https://f1000research.com/j_spring_oauth_security_check" id="facebookOAuth" method="post"  target="_top" >
                                    <input class="target-field" type="hidden" name="target" value="/articles/6-2063.html"/>
                            <input id="facebook-remember-me" name="_spring_security_oauth_remember_me" type="hidden" value="true"/>
        <input id="system-fb" name="system" type="hidden" value="FACEBOOK"/>
    </form>
            <form action="https://f1000research.com/j_spring_oauth_security_check" id="orcidOAuth" method="post"  target="_top" >
                                    <input class="target-field" type="hidden" name="target" value="/articles/6-2063.html"/>
                            <input id="orcid-remember-me" name="_spring_security_oauth_remember_me" type="hidden" value="true"/>
        <input id="system-orcid" name="system" type="hidden" value="ORCID"/>
    </form>
		<form id="sign-in-form" class="login-container" action="https://f1000research.com/login" method="post" name="f">
           <div id="sign-in-form-gfb-popup"></div>

                                                            <input class="target-field" type="hidden" name="target" value="/articles/6-2063.html"/>
                            			<input type="text" name="username" id="signin-email-box" class="sign-in-input" placeholder="Email address" autocomplete="email">
			<input type="password" name="password" id="signin-password-box" class="sign-in-input" placeholder="Password" autocomplete="current-password">
			<div class="sign-in-remember">
                <div class="checkbox-wrapper">
    				<input type="checkbox" id="remember-me" name="remember_me" class="checkbox is-hidden">
                </div>
                <span class="checkbox-label">Remember me</span>
			</div>
			<a href="#" class="sign-in-link" id="forgot-password-link">Forgotten your password?</a>
			<div class="sign-in-button-container margin-top margin-left-20 margin-bottom">
				<button type="submit" id="sign-in-button" class="sign-in-buttons general-white-orange-button">Sign In</button>
				<button type="button" id="sign-in-cancel" class="sign-in-buttons sign-in-cancel-button margin-left">Cancel</button>
				<div class="clearfix"></div>
			</div>
			<div class="sign-in-error">Email or password not correct. Please try again</div>
			<div class="sign-in-loading">Please wait...</div>
		</form>
		<div class="forgot-password-container">
			
<script type="text/javascript">
	$(function(){
		// Note: All the setup needs to run against a name attribute and *not* the id due the clonish
		// nature of facebox...
		$("a[id=googleSignInButton]").click(function(event){
            event.preventDefault();
            $("input[id=oAuthSystem]").val("GOOGLE");
            $("form[id=oAuthForm]").submit();
        });
        $("a[id=facebookSignInButton]").click(function(event){
            event.preventDefault();
            $("input[id=oAuthSystem]").val("FACEBOOK");
            $("form[id=oAuthForm]").submit();
        });
        $("a[id=orcidSignInButton]").click(function(event){
            event.preventDefault();
            $("input[id=oAuthSystem]").val("ORCID");
            $("form[id=oAuthForm]").submit();
        });
	});
</script>

<span class="text first">
	If you've forgotten your password, please enter your email address below and we'll send you instructions on how to reset your password.
    <p>The email address should be the one you originally registered with F1000.</p>
</span>
<input name="email" class="sign-in-input" id="email-forgot-password" type="text" placeholder="Email address">
<div class="forgot-password-email-error">
	Email address not valid, please try again
</div>
<div class="forgot-password-google-email-error">
    <p>You registered with F1000 via Google, so we cannot reset your password.</p>
	<p>To sign in, please click <a href="#" id="googleSignInButton">here</a>.</p>
    <p>If you still need help with your Google account password, please click <a href="https://www.google.com/accounts/recovery">here</a>.</p>
</div>
<div class="forgot-password-facebook-email-error">
    <p>You registered with F1000 via Facebook, so we cannot reset your password.</p>
    <p>To sign in, please click <a href="#" id="facebookSignInButton">here</a>.</p>
	<p>If you still need help with your Facebook account password, please click <a href="https://www.facebook.com/recover/initiate">here</a>.</p>
</div>
<div class="clearfix"></div>
<div class="forgot-password-captcha-error">
	Code not correct, please try again
</div>
<div class="clearfix"></div>
<div class="sign-in-button-container margin-left-20 margin-bottom">
	<button type="button" id="sign-in-reset-password" class="sign-in-buttons general-white-orange-button">Reset password</button>
	<button type="button" id="forgot-password-cancel" class="sign-in-buttons sign-in-cancel-button margin-left">Cancel</button>
	<div class="clearfix"></div>
</div>
<span class="text last">
	<a href="mailto:">Email us</a> for further assistance.
</span>
<form action="https://f1000research.com/j_spring_oauth_security_check" id="oAuthForm" method="post" target="_top">
                        <input class="target-field" type="hidden" name="target" value="/articles/6-2063.html"/>
                <input id="oAuthSystem" name="system" type="hidden"/>
</form>
			<div class="forgot-password-server-error">Server error, please try again.</div>
			<div class="sign-in-success">
                <p>We have sent an email to <span id="email-value"></span>, please follow the instructions to reset your password.</p>
                <p>If you don't receive this email, please check your spam filters and/or contact .</p>
            </div>
			<div class="sign-in-loading">Please wait...</div>
		</div>

		<div class="sign-in-form-register-section">
			<div class="sign-in-button-container margin-left-20 margin-bottom">
				<a href="/register" title="Register"><button type="button" id="sign-in-register-button" class="sign-in-buttons general-white-orange-button">Register</button></a>
				<div class="clearfix"></div>
			</div>
		</div>

	</div>
</div>

<script type="text/javascript">
$(document).ready(function () {

    signIn.createSignInAsRow($("#sign-in-form-gfb-popup"));

    $(".target-field").each(function () {
        var uris = $(this).val().split("/");
        if (uris.pop() === "login") {
        	$(this).val(uris.toString().replace(",","/"));
        }
    });
});
</script>
        <div id="templateOverlay" class="is-hidden" hidden="hidden">
  <div class="o-overlay js-overlay is-hidden" hidden="hidden"></div>
</div>

<div id="templateExternalMessages" class="is-hidden" hidden="hidden">
  <div class="o-modal o-modal--auto@md js-external-messages is-hidden" hidden="hidden">
    <div class="o-modal__body">
      <section class="c-console">
        <div class="_mdl-layout c-console__bdy js-external-messages-body"></div>
        <footer class="_mdl-layout c-console__ftr o-flex o-flex--reverse js-external-messages-footer">
          <button type="button" class="mdl-button mdl-js-button mdl-button--raised mdl-button--colored c-console__btn js-external-messages-close" data-action="maintenance-close">I Understand</button>
        </footer>
      </section>
    </div>
  </div>
</div>

<script src="https://cdnjs.cloudflare.com/ajax/libs/moment.js/2.22.1/moment.min.js"></script>

<script src="/js/namespace.js"></script>
<script src="/js/constants.js"></script>
<script src="/js/utilities.js"></script>

<script>
                  F1000.ExtenalMaintenanceItems = [
    {
      start: '2018-12-10T14:21:00Z',
      end: '2018-12-13T16:00:00Z',
      msg: 'This site will be down for a short time on XX December. It is advisable not to start any submissions on that day or you may lose your work unless you save regularly.',
      cookieName: 'outage23122018',
      editor: false,
    }
  ];
</script>

<script src="/js/shared_scripts/cookie-helper.js"></script>
<script src="/js/shared_scripts/mdl-helper.js"></script>

<script src="/js/app/external-maintenance.js"></script>

                <script type="text/javascript">
            (function(i,s,o,g,r,a,m){i['GoogleAnalyticsObject']=r;i[r]=i[r]||function(){
            (i[r].q=i[r].q||[]).push(arguments)},i[r].l=1*new Date();a=s.createElement(o),
            m=s.getElementsByTagName(o)[0];a.async=1;a.src=g;m.parentNode.insertBefore(a,m)
            })(window,document,'script','//www.google-analytics.com/analytics.js','ga');

            ga('create', 'UA-5646075-11', 'auto');
            ga('require', 'displayfeatures');
            ga('send', 'pageview');
        </script>
        
                <script type="text/javascript" src="/js/app/research.analytics.js"></script>

        <!-- Start of HubSpot Embed Code -->
        <script type="text/javascript" id="hs-script-loader" async defer src="//js.hs-scripts.com/4475190.js"></script>
        <!-- End of HubSpot Embed Code -->
    
            <script src="https://my.hellobar.com/4e0495c6f18cbd68731a1dc1978195a144e767ba.js" type="text/javascript" charset="utf-8" async="async"></script>
    </body>

</html>